(459620, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013134', 'poor circulation in autopods', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459621, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459622, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031240', 'abnormal CSF3 level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459623, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013627', 'increased vertebra yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459624, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009057', 'increased interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459625, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004781', 'abnormal surfactant composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459626, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459627, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005088', 'increased acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459628, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003474', 'abnormal summary potential intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459629, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011809', 'abnormal anoikis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459630, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005253', 'abnormal eye physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459631, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459632, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003091', 'abnormal cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459633, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002420', 'abnormal adaptive immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459634, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005532', 'abnormal vascular resistance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459635, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459636, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001598', 'abnormal blood viscosity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459637, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459638, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008004', 'abnormal stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459639, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005551', 'abnormal eye electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459640, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0000505', 'decreased digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459641, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002418', 'increased susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459642, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031127', 'dry gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459643, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005575', 'increased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459644, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004484', 'abnormal response of heart to induced stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459645, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459646, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459647, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459648, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459649, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459650, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459651, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020097', 'low mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459652, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459653, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003726', 'decreased autoantibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459654, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010695', 'abnormal blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459655, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003698', 'abnormal male reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459656, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003866', 'abnormal defecation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459657, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011194', 'abnormal hair follicle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459658, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008688', 'decreased interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459659, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0014132', 'abnormal tear film physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459660, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0000316', 'cellular necrosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459661, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004994', 'abnormal brain wave pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459662, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011418', 'leukocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459663, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003464', 'abnormal single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459664, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459665, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020154', 'impaired humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459666, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003746', 'stomatitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459667, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008002', 'hyperchlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459668, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011930', 'abnormal tricuspid valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459669, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459670, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459671, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0030129', 'tongue inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459672, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459673, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003341', 'chronic pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459674, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010922', 'alveolitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459675, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459676, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004011', 'decreased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459677, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459678, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008679', 'decreased interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459679, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459680, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459681, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459682, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001935', 'decreased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459683, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459684, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004782', 'abnormal surfactant physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459685, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011045', 'decreased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459686, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001867', 'rhinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459687, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459688, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459689, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004213', 'abnormal umami taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459690, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459691, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459692, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008260', 'abnormal autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459693, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459694, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459695, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010946', 'hyperpnea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459696, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031066', 'cytokine storm', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459697, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003762', 'abnormal immune organ physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459698, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011046', 'abnormal lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459699, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459700, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0030153', 'dental pulp inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459701, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004742', 'abnormal vestibular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459702, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459703, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001665', 'chronic diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459704, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003674', 'oxidative stress', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459705, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013136', 'genital discharge', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459706, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013459', 'perioral dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459707, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0014120', 'focal seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459708, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011764', 'ureteritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459709, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459710, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459711, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011804', 'increased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459712, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011918', 'abnormal PQ interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459713, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009732', 'ventricular premature beat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459714, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011431', 'increased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459715, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002500', 'granulomatous inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459716, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459717, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008699', 'increased interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459718, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013641', 'increased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459719, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0030909', 'abnormal melanocyte adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459720, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013639', 'decreased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459721, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459722, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0030990', 'nerve inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459723, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0000503', 'excessive digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459724, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459725, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459726, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003560', 'osteoarthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459727, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003259', 'nausea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459728, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008664', 'decreased interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459729, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459730, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031090', 'ageusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459731, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008682', 'decreased interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459732, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459733, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009562', 'abnormal odor adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459734, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011432', 'decreased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459735, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459736, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002064', 'seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459737, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459738, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001954', 'respiratory distress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459739, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002933', 'joint inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459740, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020080', 'increased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459741, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459742, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005004', 'abnormal lymphocyte anergy', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459743, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459744, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459745, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020000', 'abnormal response to antigen', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459746, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002334', 'abnormal airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459747, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459748, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459749, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012608', 'abnormal complement C5 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459750, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020848', 'abnormal exocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459751, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459752, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459753, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001924', 'infertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459754, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001756', 'abnormal urination', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459755, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459756, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010394', 'decreased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459757, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001629', 'abnormal heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459758, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459759, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008711', 'increased interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459760, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031102', 'rhinorrhea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459761, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459762, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0014274', 'decreased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459763, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459764, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459765, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0000947', 'convulsive seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459766, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010954', 'abnormal cellular respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459767, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459768, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010636', 'bundle branch block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459769, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008708', 'increased interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459770, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011566', 'abnormal complement protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459771, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020845', 'abnormal DNA-templated transcription', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459772, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459773, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011926', 'abnormal heart valve physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459774, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010538', 'increased level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459775, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008678', 'increased interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459776, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008651', 'increased interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459777, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003900', 'shortened QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459778, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008709', 'decreased interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459779, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459780, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003306', 'small intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459781, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459782, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002934', 'acute joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459783, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008675', 'increased interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459784, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459785, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031469', 'abnormal pinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459786, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013806', 'encephalopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459787, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004945', 'abnormal bone resorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459788, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005085', 'abnormal gallbladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459789, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003476', 'decreased summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459790, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031054', 'bronchiolitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459791, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001633', 'poor circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459792, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459793, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011013', 'bronchiolectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459794, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003011', 'delayed dark adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459795, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011012', 'bronchiectasis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459796, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459797, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011954', 'shortened PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459798, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459799, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459800, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459801, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001793', 'abnormal susceptibility to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459802, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002292', 'abnormal gestational length', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459803, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459804, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459805, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002998', 'abnormal bone remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459806, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004072', 'abnormal frontal plane axis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459807, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459808, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004036', 'abnormal muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459809, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0006046', 'atrioventricular valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459810, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459811, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003878', 'abnormal ear physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459812, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008564', 'increased interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459813, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010504', 'abnormal RR interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459814, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010554', 'shortened HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459815, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005580', 'periinsulitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459816, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459817, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459818, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011718', 'decreased interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459819, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010571', 'shortened ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459820, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012556', 'increased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459821, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001933', 'abnormal litter size', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459822, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003928', 'increased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459823, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459824, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005515', 'uveitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459825, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031222', 'decreased CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459826, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459827, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002635', 'reduced sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459828, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0006049', 'semilunar valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459829, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459830, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009384', 'cardiac valve regurgitation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459831, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008696', 'increased interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459832, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459833, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011937', 'shortened PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459834, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459835, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008722', 'abnormal chemokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459836, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459837, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008685', 'decreased interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459838, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031223', 'increased CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459839, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459840, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459841, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003898', 'abnormal QRS complex', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459842, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459843, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005576', 'decreased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459844, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001846', 'increased inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459845, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459846, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003824', 'decreased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459847, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011925', 'abnormal heart echocardiography feature', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459848, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459849, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0000304', 'abnormal cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459850, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002578', 'impaired ability to fire action potentials', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459851, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013637', 'increased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459852, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459853, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001857', 'pericarditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459854, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459855, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031091', 'hypogeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459856, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010393', 'shortened QRS complex duration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459857, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031086', 'wheezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459858, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004759', 'decreased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459859, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009788', 'increased susceptibility to bacterial infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459860, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459861, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005402', 'abnormal action potential', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459862, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008009', 'delayed cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459863, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0006043', 'decreased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459864, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003926', 'decreased cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459865, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459866, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459867, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031130', 'right-to-left shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459868, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001840', 'increased level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459869, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010560', 'intraventricular block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459870, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0000743', 'muscle spasm', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459871, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012609', 'decreased complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459872, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011762', 'renal/urinary system inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459873, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008750', 'abnormal interferon level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459874, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009792', 'seborrheic dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459875, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008690', 'increased interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459876, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008563', 'decreased interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459877, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013135', 'poor circulation in tail', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459878, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459879, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459880, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459881, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459882, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013478', 'corneal limbitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459883, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459884, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031424', 'enhanced female fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459885, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004780', 'abnormal surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459886, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459887, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005620', 'abnormal muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459888, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001627', 'abnormal cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459889, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008861', 'abnormal hair shedding', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459890, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010756', 'decreased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459891, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459892, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010950', 'abnormal lung hysteresivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459893, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459894, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013640', 'increased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459895, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459896, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001636', 'irregular heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459897, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008712', 'decreased interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459898, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459899, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0006266', 'decreased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459900, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003659', 'abnormal lymph circulation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459901, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003465', 'increased single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459902, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011994', 'increased nerve conduction velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459903, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459904, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459905, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459906, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031053', 'pleuritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459907, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0000351', 'increased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459908, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011043', 'abnormal lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459909, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459910, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459911, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002694', 'abnormal pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459912, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459913, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031306', 'abnormal cartilage physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459914, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459915, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008001', 'hypochlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459916, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0021015', 'increased tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459917, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001853', 'heart inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459918, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001862', 'interstitial pneumonia', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459919, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013634', 'increased femur fracture load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459920, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459921, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002841', 'impaired skeletal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459922, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459923, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003480', 'increased nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459924, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0030132', 'periodontium inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459925, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001847', 'brain inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459926, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009567', 'mitotic nondisjunction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459927, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001947', 'abnormal mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459928, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008814', 'decreased nerve conduction velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459929, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010520', 'sinoatrial block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459930, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013971', 'blood in lymph vessels', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459931, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459932, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459933, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001919', 'abnormal reproductive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459934, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0006042', 'increased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459935, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459936, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002472', 'impaired complement alternative pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459937, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459938, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011047', 'increased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459939, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031014', 'polyspermy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459940, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003482', 'increased nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459941, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003039', 'increased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459942, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009062', 'impaired lectin complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459943, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001850', 'increased susceptibility to otitis media', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459944, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459945, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001845', 'abnormal inflammatory response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459946, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012554', 'increased serum complement activity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459947, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011044', 'increased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459948, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459949, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459950, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459951, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459952, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459953, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459954, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459955, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0006003', 'abnormal large intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459956, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001983', 'abnormal olfactory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459957, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459958, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459959, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020002', 'increased response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459960, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459961, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020155', 'enhanced humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459962, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0030988', 'dysosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459963, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003566', 'abnormal cell adhesion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459964, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008691', 'decreased interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459965, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459966, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005000', 'abnormal immune tolerance', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459967, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0006336', 'abnormal otoacoustic response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459968, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002842', 'increased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459969, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459970, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002419', 'abnormal innate immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459971, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0006082', 'CNS inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459972, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031241', 'decreased CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459973, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009045', 'muscle tetany', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459974, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008721', 'abnormal chemokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459975, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009791', 'increased susceptibility to viral infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459976, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003077', 'abnormal cell cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459977, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001800', 'abnormal humoral immune response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459978, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012200', 'increased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459979, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459980, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008775', 'abnormal heart ventricle pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459981, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031092', 'dysgeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459982, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459983, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011931', 'abnormal pulmonary valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459984, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002406', 'increased susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459985, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0011928', 'abnormal mitral valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459986, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009790', 'decreased susceptibility to viral infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459987, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459988, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459989, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008713', 'abnormal cytokine level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459990, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001945', 'bronchoconstriction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459991, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013498', 'trachea inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459992, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459993, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005403', 'abnormal nerve conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459994, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459995, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459996, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003471', 'abnormal summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(459997, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008670', 'decreased interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459998, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(459999, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460000, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0030214', 'muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460001, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031118', 'cardiovalvulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460002, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010993', 'decreased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460003, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002164', 'abnormal gland physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460004, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001873', 'stomach inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460005, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009697', 'abnormal copulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460006, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001912', 'increased cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460007, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004212', 'abnormal salty taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460008, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460009, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031095', 'pharyngitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460010, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031246', 'abnormal CCL3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460011, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031089', 'sneezing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460012, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460013, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031480', 'abnormal urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460014, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0030940', 'impaired autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460015, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001864', 'vascular inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460016, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003157', 'impaired muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460017, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460018, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008669', 'increased interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460019, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008003', 'achlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460020, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008673', 'decreased interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460021, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001950', 'abnormal respiratory sounds', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460022, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010552', 'abnormal HV interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460023, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460024, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020147', 'abnormal defecation amount', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460025, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460026, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460027, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005076', 'abnormal cell differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460028, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002471', 'abnormal complement pathway', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460029, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013460', 'periocular dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460030, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008555', 'abnormal interferon secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460031, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460032, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001841', 'decreased level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460033, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003880', 'abnormal central pattern generator function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460034, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012685', 'abnormal primitive streak elongation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460035, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004144', 'hypotonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460036, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013642', 'decreased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460037, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010570', 'prolonged ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460038, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013556', 'abnormal holocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460039, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008697', 'decreased interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460040, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460041, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460042, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460043, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002128', 'abnormal blood circulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460044, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460045, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010377', 'abnormal gut flora balance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460046, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460047, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020414', 'abnormal fibroblast physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460048, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460049, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003454', 'erythroderma', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460050, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008687', 'increased interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460051, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001876', 'decreased inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460052, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002296', 'aspiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460053, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003233', 'prolonged QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460054, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004512', 'anosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460055, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460056, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460057, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460058, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002133', 'abnormal respiratory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460059, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004010', 'increased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460060, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0013638', 'decreased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460061, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460062, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460063, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460064, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460065, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0030118', 'rhinosinusitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460066, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020096', 'high mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460067, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004878', 'increased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460068, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008693', 'increased interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460069, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012197', 'impaired myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460070, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003251', 'gallbladder inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460071, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010994', 'aerophagia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460072, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460073, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460074, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031051', 'lymph node hemorrhage', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460075, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004122', 'abnormal sinus arrhythmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460076, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460077, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004796', 'increased anti-histone antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460078, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010758', 'increased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460079, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460080, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008539', 'decreased susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460081, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009348', 'abnormal urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460082, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003477', 'abnormal nerve fiber response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460083, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002634', 'abnormal sensorimotor gating', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460084, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0030216', 'tongue muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460085, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460086, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003280', 'urinary incontinence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460087, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012610', 'increased complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460088, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003633', 'abnormal nervous system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460089, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031104', 'crackles', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460090, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003304', 'large intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460091, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460092, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003122', 'maternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460093, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0005087', 'decreased acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460094, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031105', 'rhonchi', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460095, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460096, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460097, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010896', 'decreased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460098, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0004947', 'skin inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460099, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003767', 'palate inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460100, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0001819', 'abnormal immune cell physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460101, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003927', 'increased cellular glucose import', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460102, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003875', 'abnormal hair follicle regression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460103, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0010822', 'pneumothorax', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460104, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0031247', 'decreased CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460105, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460106, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0009058', 'decreased interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460107, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0020381', 'muscle gating pore current', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460108, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0008950', 'ventricular tachycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460109, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0003865', 'lymph node inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460110, 'HP:0011112', 'Abnormal circulating cytokine concentration', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460111, 'HP:0002783', 'Recurrent lower respiratory tract infections', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(460112, 'HP:0002783', 'Recurrent lower respiratory tract infections', 'MP:0005586', 'decreased tidal volume', 0.4166666666666667, 9.915985363358194, 2.032648658294373, 'UPHENO:0019970', 'abnormal lung morphology'),
(460113, 'HP:0002783', 'Recurrent lower respiratory tract infections', 'MP:0002306', 'abnormal functional residual capacity', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(460114, 'HP:0002783', 'Recurrent lower respiratory tract infections', 'MP:0002311', 'abnormal inspiratory capacity', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(460115, 'HP:0002783', 'Recurrent lower respiratory tract infections', 'MP:0002308', 'abnormal residual volume', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(460116, 'HP:0002783', 'Recurrent lower respiratory tract infections', 'MP:0010938', 'decreased total lung capacity', 0.40816326530612246, 9.915985363358194, 2.0118004286300364, 'UPHENO:0019970', 'abnormal lung morphology'),
(460117, 'HP:0002783', 'Recurrent lower respiratory tract infections', 'MP:0010937', 'increased total lung capacity', 0.40816326530612246, 9.915985363358194, 2.0118004286300364, 'UPHENO:0019970', 'abnormal lung morphology'),
(460118, 'HP:0002783', 'Recurrent lower respiratory tract infections', 'MP:0002337', 'abnormal whole-body plethysmography', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(460119, 'HP:0002783', 'Recurrent lower respiratory tract infections', 'MP:0002313', 'abnormal tidal volume', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(460120, 'HP:0002783', 'Recurrent lower respiratory tract infections', 'MP:0001942', 'abnormal lung volume', 0.43478260869565216, 9.915985363358194, 2.0763665341333115, 'UPHENO:0019970', 'abnormal lung morphology'),
(460121, 'HP:0002783', 'Recurrent lower respiratory tract infections', 'MP:0002304', 'abnormal total lung capacity', 0.4166666666666667, 9.915985363358194, 2.032648658294373, 'UPHENO:0019970', 'abnormal lung morphology'),
(460122, 'HP:0002783', 'Recurrent lower respiratory tract infections', 'MP:0005585', 'increased tidal volume', 0.4166666666666667, 9.915985363358194, 2.032648658294373, 'UPHENO:0019970', 'abnormal lung morphology'),
(460123, 'HP:0002783', 'Recurrent lower respiratory tract infections', 'MP:0002309', 'abnormal vital capacity', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(460124, 'HP:0007656', 'Lacrimal gland aplasia', 'MP:0014148', 'lacrimal gland degeneration', 0.4307692307692308, 13.799792345853671, 2.4381398511157033, 'UPHENO:0020995', 'abnormal lacrimal gland morphology'),
(460125, 'HP:0007656', 'Lacrimal gland aplasia', 'MP:0014150', 'lacrimal gland hyperplasia', 0.4057971014492754, 13.799792345853671, 2.3664141088468256, 'UPHENO:0020995', 'abnormal lacrimal gland morphology'),
(460126, 'HP:0007656', 'Lacrimal gland aplasia', 'MP:0014151', 'lacrimal gland hypoplasia', 0.43478260869565216, 15.384754846574829, 2.586314722986528, 'UPHENO:0080192', 'aplasia or hypoplasia of lacrimal gland'),
(460127, 'HP:0007656', 'Lacrimal gland aplasia', 'MP:0013455', 'lacrimal gland atrophy', 0.417910447761194, 13.799792345853671, 2.401474005328229, 'UPHENO:0020995', 'abnormal lacrimal gland morphology'),
(460128, 'HP:0007656', 'Lacrimal gland aplasia', 'MP:0013453', 'enlarged lacrimal gland', 0.42424242424242425, 13.799792345853671, 2.4195985945703913, 'UPHENO:0020995', 'abnormal lacrimal gland morphology'),
(460129, 'HP:0010551', 'Paraplegia/paraparesis', 'MP:0010653', 'abnormal Wallerian degeneration', 0.425, 11.437222266468964, 2.2047266187101995, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(460130, 'HP:0010551', 'Paraplegia/paraparesis', 'MP:0005621', 'abnormal cell physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(460131, 'HP:0010551', 'Paraplegia/paraparesis', 'MP:0010654', 'slow Wallerian degeneration', 0.4146341463414634, 11.437222266468964, 2.177673733821239, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(460132, 'HP:0010551', 'Paraplegia/paraparesis', 'MP:0003633', 'abnormal nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460133, 'HP:0010551', 'Paraplegia/paraparesis', 'MP:0021001', 'impaired neuron physiology', 0.4473684210526316, 11.437222266468964, 2.2620017830625647, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(460134, 'HP:0010551', 'Paraplegia/paraparesis', 'MP:0009967', 'abnormal neuron proliferation', 0.4358974358974359, 11.437222266468964, 2.23281344042508, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(460135, 'HP:0010551', 'Paraplegia/paraparesis', 'MP:0003202', 'abnormal neuron apoptosis', 0.425, 11.437222266468964, 2.2047266187101995, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(460136, 'HP:0010551', 'Paraplegia/paraparesis', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4473684210526316, 11.437222266468964, 2.2620017830625647, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(460137, 'HP:0010551', 'Paraplegia/paraparesis', 'MP:0004768', 'abnormal axonal transport', 0.4473684210526316, 11.437222266468964, 2.2620017830625647, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(460138, 'HP:0010551', 'Paraplegia/paraparesis', 'MP:0004811', 'abnormal neuron physiology', 0.4594594594594595, 11.437222266468964, 2.2923655817232826, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(460139, 'HP:0010551', 'Paraplegia/paraparesis', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4473684210526316, 11.437222266468964, 2.2620017830625647, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(460140, 'HP:0006383', 'Progressive bowing of long bones', 'MP:0004358', 'bowed tibia', 0.4050632911392405, 11.022184767190119, 2.112979516545968, 'UPHENO:0041610', 'curved long bone'),
(460141, 'HP:0006383', 'Progressive bowing of long bones', 'MP:0004371', 'bowed femur', 0.41025641025641024, 11.022184767190119, 2.1264811204829224, 'UPHENO:0041610', 'curved long bone'),
(460142, 'HP:0004854', 'Intermittent thrombocytopenia', 'MP:0013661', 'abnormal myeloid cell number', 0.40384615384615385, 10.175301480945878, 2.0271300814957747, 'UPHENO:0086005', 'abnormal number of anatomical enitites of type myeloid cell'),
(460143, 'HP:0004854', 'Intermittent thrombocytopenia', 'MP:0005505', 'thrombocytosis', 0.40625, 13.548253578857707, 2.34605584256022, 'UPHENO:0086049', 'abnormal number of anatomical enitites of type platelet'),
(460144, 'HP:0004854', 'Intermittent thrombocytopenia', 'MP:0002875', 'decreased erythrocyte cell number', 0.40298507462686567, 11.533898285880637, 2.155919493272948, 'UPHENO:0085344', 'abnormally decreased number of myeloid cell'),
(460145, 'HP:0004854', 'Intermittent thrombocytopenia', 'MP:0011898', 'abnormal platelet cell number', 0.4642857142857143, 13.548253578857707, 2.508039192314174, 'UPHENO:0086049', 'abnormal number of anatomical enitites of type platelet'),
(460146, 'HP:0004854', 'Intermittent thrombocytopenia', 'MP:0003714', 'absent platelets', 0.4492753623188406, 14.285219173023913, 2.533376604408505, 'UPHENO:0085302', 'abnormally decreased number of platelet'),
(460147, 'HP:0004854', 'Intermittent thrombocytopenia', 'MP:0011182', 'decreased hematopoietic cell number', 0.43137254901960786, 9.892901750245153, 2.0657991783336036, 'UPHENO:0085371', 'abnormally decreased number of hematopoietic cell'),
(460148, 'HP:0004854', 'Intermittent thrombocytopenia', 'MP:0013662', 'decreased myeloid cell number', 0.46296296296296297, 11.533898285880637, 2.310793743488315, 'UPHENO:0085344', 'abnormally decreased number of myeloid cell'),
(460149, 'HP:0004854', 'Intermittent thrombocytopenia', 'MP:0003179', 'thrombocytopenia', 0.5254237288135594, 14.285219173023913, 2.739670258408697, 'UPHENO:0085302', 'abnormally decreased number of platelet'),
(460150, 'HP:0031350', 'Cardiac sarcoma', 'MP:0005406', 'abnormal heart size', 0.40625, 7.506484928906078, 1.7462844849474253, 'UPHENO:0076810', 'abnormal heart morphology'),
(460151, 'HP:0031350', 'Cardiac sarcoma', 'MP:0000288', 'abnormal pericardium morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460152, 'HP:0031350', 'Cardiac sarcoma', 'MP:0010440', 'anomalous pulmonary venous connection', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460153, 'HP:0031350', 'Cardiac sarcoma', 'MP:0010433', 'double inlet heart left ventricle', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460154, 'HP:0031350', 'Cardiac sarcoma', 'MP:0010426', 'abnormal heart and great artery attachment', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460155, 'HP:0031350', 'Cardiac sarcoma', 'MP:0005294', 'abnormal heart ventricle morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460156, 'HP:0031350', 'Cardiac sarcoma', 'MP:0011511', 'biventricular, ambiguous atrioventricular connection', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460157, 'HP:0031350', 'Cardiac sarcoma', 'MP:0003279', 'aneurysm', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(460158, 'HP:0031350', 'Cardiac sarcoma', 'MP:0000644', 'dextrocardia', 0.40625, 7.506484928906078, 1.7462844849474253, 'UPHENO:0076810', 'abnormal heart morphology'),
(460159, 'HP:0031350', 'Cardiac sarcoma', 'MP:0013332', 'peliosis', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(460160, 'HP:0031350', 'Cardiac sarcoma', 'MP:0012515', 'abnormal heart apex morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460161, 'HP:0031350', 'Cardiac sarcoma', 'MP:0000650', 'mesocardia', 0.40625, 7.506484928906078, 1.7462844849474253, 'UPHENO:0076810', 'abnormal heart morphology'),
(460162, 'HP:0031350', 'Cardiac sarcoma', 'MP:0002837', 'dystrophic cardiac calcinosis', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(460163, 'HP:0031350', 'Cardiac sarcoma', 'MP:0012687', 'abnormal heart atrium weight', 0.40625, 7.506484928906078, 1.7462844849474253, 'UPHENO:0076810', 'abnormal heart morphology'),
(460164, 'HP:0031350', 'Cardiac sarcoma', 'MP:0002839', 'increased susceptibility to dystrophic cardiac calcinosis', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460165, 'HP:0031350', 'Cardiac sarcoma', 'MP:0011510', 'biventricular, discordant atrioventricular connection', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460166, 'HP:0031350', 'Cardiac sarcoma', 'MP:0000285', 'abnormal heart valve morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460167, 'HP:0031350', 'Cardiac sarcoma', 'MP:0010434', 'double inlet heart right ventricle', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460168, 'HP:0031350', 'Cardiac sarcoma', 'MP:0010435', 'abnormal heart atrium and ventricle connection', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(460169, 'HP:0031350', 'Cardiac sarcoma', 'MP:0000266', 'abnormal heart morphology', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(460170, 'HP:0031350', 'Cardiac sarcoma', 'MP:0002838', 'decreased susceptibility to dystrophic cardiac calcinosis', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460171, 'HP:0031350', 'Cardiac sarcoma', 'MP:0006113', 'abnormal heart septum morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460172, 'HP:0031350', 'Cardiac sarcoma', 'MP:0003141', 'cardiac fibrosis', 0.40625, 7.506484928906078, 1.7462844849474253, 'UPHENO:0076810', 'abnormal heart morphology'),
(460173, 'HP:0031350', 'Cardiac sarcoma', 'MP:0010425', 'abnormal heart and great vessel attachment', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(460174, 'HP:0031350', 'Cardiac sarcoma', 'MP:0010545', 'abnormal heart layer morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460175, 'HP:0031350', 'Cardiac sarcoma', 'MP:0000267', 'abnormal heart development', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460176, 'HP:0031350', 'Cardiac sarcoma', 'MP:0003105', 'abnormal heart atrium morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460177, 'HP:0031350', 'Cardiac sarcoma', 'MP:0011660', 'ectopia cordis', 0.40625, 7.506484928906078, 1.7462844849474253, 'UPHENO:0076810', 'abnormal heart morphology'),
(460178, 'HP:0031350', 'Cardiac sarcoma', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(460179, 'HP:0031350', 'Cardiac sarcoma', 'MP:0010551', 'abnormal coronary vessel morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(460180, 'HP:0031350', 'Cardiac sarcoma', 'MP:0003228', 'abnormal sinus venosus morphology', 0.40625, 7.506484928906078, 1.7462844849474253, 'UPHENO:0076810', 'abnormal heart morphology'),
(460181, 'HP:0031350', 'Cardiac sarcoma', 'MP:0002925', 'abnormal cardiovascular development', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(460182, 'HP:0031350', 'Cardiac sarcoma', 'MP:0006065', 'abnormal heart position or orientation', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(460183, 'HP:0031350', 'Cardiac sarcoma', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(460184, 'HP:0006384', 'Club-shaped distal femur', 'MP:0030793', 'short femur neck', 0.4225352112676056, 10.700256672302757, 2.1263196405171665, 'UPHENO:0087558', 'abnormal femur morphology'),
(460185, 'HP:0006384', 'Club-shaped distal femur', 'MP:0030826', 'decreased femur weight', 0.4383561643835616, 11.359219754467691, 2.2314533385124684, 'UPHENO:0020967', 'abnormal femur morphology'),
(460186, 'HP:0006384', 'Club-shaped distal femur', 'MP:0030791', 'club-shaped femur', 0.45714285714285713, 11.359219754467691, 2.27876856514016, 'UPHENO:0020967', 'abnormal femur morphology'),
(460187, 'HP:0006384', 'Club-shaped distal femur', 'MP:0008152', 'decreased diameter of femur', 0.49230769230769234, 11.359219754467691, 2.364789898434519, 'UPHENO:0020967', 'abnormal femur morphology'),
(460188, 'HP:0006384', 'Club-shaped distal femur', 'MP:0030825', 'decreased femur size', 0.5079365079365079, 11.359219754467691, 2.402032975412227, 'UPHENO:0020967', 'abnormal femur morphology'),
(460189, 'HP:0006384', 'Club-shaped distal femur', 'MP:0004357', 'long tibia', 0.4027777777777778, 7.694257931681313, 1.7604192998747883, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(460190, 'HP:0006384', 'Club-shaped distal femur', 'MP:0030824', 'increased femur weight', 0.45714285714285713, 11.359219754467691, 2.27876856514016, 'UPHENO:0020967', 'abnormal femur morphology'),
(460191, 'HP:0006384', 'Club-shaped distal femur', 'MP:0004348', 'long femur', 0.45714285714285713, 11.359219754467691, 2.27876856514016, 'UPHENO:0020967', 'abnormal femur morphology'),
(460192, 'HP:0006384', 'Club-shaped distal femur', 'MP:0000482', 'long fibula', 0.4027777777777778, 7.694257931681313, 1.7604192998747883, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(460193, 'HP:0006384', 'Club-shaped distal femur', 'MP:0030792', 'large femur head', 0.43478260869565216, 10.700256672302757, 2.1569157400549637, 'UPHENO:0087558', 'abnormal femur morphology'),
(460194, 'HP:0006384', 'Club-shaped distal femur', 'MP:0030823', 'increased femur size', 0.5079365079365079, 11.359219754467691, 2.402032975412227, 'UPHENO:0020967', 'abnormal femur morphology'),
(460195, 'HP:0006384', 'Club-shaped distal femur', 'MP:0002764', 'short tibia', 0.4027777777777778, 7.694257931681313, 1.7604192998747883, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(460196, 'HP:0006384', 'Club-shaped distal femur', 'MP:0030827', 'femur fracture', 0.5161290322580645, 11.359219754467691, 2.421326722910417, 'UPHENO:0020967', 'abnormal femur morphology'),
(460197, 'HP:0006384', 'Club-shaped distal femur', 'MP:0002765', 'short fibula', 0.4027777777777778, 7.694257931681313, 1.7604192998747883, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(460198, 'HP:0006384', 'Club-shaped distal femur', 'MP:0030794', 'broad femur neck', 0.42857142857142855, 10.700256672302757, 2.1414537791252353, 'UPHENO:0087558', 'abnormal femur morphology'),
(460199, 'HP:0006384', 'Club-shaped distal femur', 'MP:0008158', 'increased diameter of femur', 0.49230769230769234, 11.359219754467691, 2.364789898434519, 'UPHENO:0020967', 'abnormal femur morphology'),
(460200, 'HP:0006384', 'Club-shaped distal femur', 'MP:0004371', 'bowed femur', 0.4155844155844156, 11.359219754467691, 2.17272057641, 'UPHENO:0020967', 'abnormal femur morphology'),
(460201, 'HP:0006384', 'Club-shaped distal femur', 'MP:0003109', 'short femur', 0.45714285714285713, 11.359219754467691, 2.27876856514016, 'UPHENO:0020967', 'abnormal femur morphology'),
(460202, 'HP:0006384', 'Club-shaped distal femur', 'MP:0000559', 'abnormal femur morphology', 0.41379310344827586, 10.700256672302757, 2.104208263486597, 'UPHENO:0087558', 'abnormal femur morphology'),
(460203, 'HP:0002107', 'Pneumothorax', 'MP:0003641', 'small lung', 0.4146341463414634, 9.915985363358194, 2.0276849178978646, 'UPHENO:0019970', 'abnormal lung morphology'),
(460204, 'HP:0002107', 'Pneumothorax', 'MP:0031098', 'abnormal sputum production', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(460205, 'HP:0002107', 'Pneumothorax', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(460206, 'HP:0002107', 'Pneumothorax', 'MP:0002309', 'abnormal vital capacity', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(460207, 'HP:0002107', 'Pneumothorax', 'MP:0011043', 'abnormal lung elastance', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(460208, 'HP:0002107', 'Pneumothorax', 'MP:0003298', 'choking', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(460209, 'HP:0002107', 'Pneumothorax', 'MP:0010937', 'increased total lung capacity', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(460210, 'HP:0002107', 'Pneumothorax', 'MP:0005585', 'increased tidal volume', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(460211, 'HP:0002107', 'Pneumothorax', 'MP:0002311', 'abnormal inspiratory capacity', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(460212, 'HP:0002107', 'Pneumothorax', 'MP:0002313', 'abnormal tidal volume', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(460213, 'HP:0002107', 'Pneumothorax', 'MP:0010938', 'decreased total lung capacity', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(460214, 'HP:0002107', 'Pneumothorax', 'MP:0001942', 'abnormal lung volume', 0.5, 9.915985363358194, 2.2266550432608767, 'UPHENO:0019970', 'abnormal lung morphology'),
(460215, 'HP:0002107', 'Pneumothorax', 'MP:0010822', 'pneumothorax', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(460216, 'HP:0002107', 'Pneumothorax', 'MP:0003828', 'pulmonary edema', 0.4146341463414634, 9.915985363358194, 2.0276849178978646, 'UPHENO:0019970', 'abnormal lung morphology'),
(460217, 'HP:0002107', 'Pneumothorax', 'MP:0002304', 'abnormal total lung capacity', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(460218, 'HP:0002107', 'Pneumothorax', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(460219, 'HP:0002107', 'Pneumothorax', 'MP:0011162', 'abnormal wet-to-dry lung weight ratio', 0.4146341463414634, 9.915985363358194, 2.0276849178978646, 'UPHENO:0019970', 'abnormal lung morphology'),
(460220, 'HP:0002107', 'Pneumothorax', 'MP:0005629', 'abnormal lung weight', 0.425, 9.915985363358194, 2.052874516239907, 'UPHENO:0019970', 'abnormal lung morphology'),
(460221, 'HP:0002107', 'Pneumothorax', 'MP:0031088', 'coughing', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(460222, 'HP:0002107', 'Pneumothorax', 'MP:0002308', 'abnormal residual volume', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(460223, 'HP:0002107', 'Pneumothorax', 'MP:0001947', 'abnormal mucociliary clearance', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(460224, 'HP:0002107', 'Pneumothorax', 'MP:0002337', 'abnormal whole-body plethysmography', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(460225, 'HP:0002107', 'Pneumothorax', 'MP:0010857', 'pulmonary necrosis', 0.4418604651162791, 9.915985363358194, 2.093198964441667, 'UPHENO:0019970', 'abnormal lung morphology'),
(460226, 'HP:0002107', 'Pneumothorax', 'MP:0031102', 'rhinorrhea', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(460227, 'HP:0002107', 'Pneumothorax', 'MP:0010950', 'abnormal lung hysteresivity', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(460228, 'HP:0002107', 'Pneumothorax', 'MP:0001958', 'emphysema', 0.4146341463414634, 9.150450616995217, 1.9478422113245026, 'UPHENO:0086908', 'abnormal lung morphology'),
(460229, 'HP:0002107', 'Pneumothorax', 'MP:0005586', 'decreased tidal volume', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(460230, 'HP:0002107', 'Pneumothorax', 'MP:0004881', 'abnormal lung size', 0.4594594594594595, 9.915985363358194, 2.1344772837995882, 'UPHENO:0019970', 'abnormal lung morphology'),
(460231, 'HP:0002107', 'Pneumothorax', 'MP:0006050', 'pulmonary fibrosis', 0.4594594594594595, 9.915985363358194, 2.1344772837995882, 'UPHENO:0019970', 'abnormal lung morphology'),
(460232, 'HP:0002107', 'Pneumothorax', 'MP:0002306', 'abnormal functional residual capacity', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(460233, 'HP:0002107', 'Pneumothorax', 'MP:0011163', 'increased wet-to-dry lung weight ratio', 0.40476190476190477, 9.915985363358194, 2.00340039015271, 'UPHENO:0019970', 'abnormal lung morphology'),
(460234, 'HP:0002107', 'Pneumothorax', 'MP:0002133', 'abnormal respiratory system physiology', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(460235, 'HP:0002107', 'Pneumothorax', 'MP:0003426', 'pulmonary interstitial fibrosis', 0.40476190476190477, 9.915985363358194, 2.00340039015271, 'UPHENO:0019970', 'abnormal lung morphology'),
(460236, 'HP:0002107', 'Pneumothorax', 'MP:0031089', 'sneezing', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(460237, 'HP:0002107', 'Pneumothorax', 'MP:0001943', 'abnormal respiration', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(460238, 'HP:0002107', 'Pneumothorax', 'MP:0011046', 'abnormal lung tissue damping', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(460239, 'HP:0003334', 'Elevated circulating catecholamine level', 'MP:0008821', 'increased blood uric acid level', 0.4084507042253521, 9.963291078136551, 2.0173034618686008, 'UPHENO:0068442', 'increased level of nitrogen molecular entity in blood'),
(460240, 'HP:0003334', 'Elevated circulating catecholamine level', 'MP:0005568', 'increased circulating total protein level', 0.43661971830985913, 9.97294124817027, 2.086715792458781, 'UPHENO:0082534', 'increased bodily fluid base level'),
(460241, 'HP:0003334', 'Elevated circulating catecholamine level', 'MP:0005665', 'increased circulating noradrenaline level', 0.47368421052631576, 15.607147267911275, 2.7189812857334084, 'UPHENO:0068363', 'increased level of catecholamine in blood'),
(460242, 'HP:0003334', 'Elevated circulating catecholamine level', 'MP:0005565', 'increased blood urea nitrogen level', 0.4142857142857143, 9.963291078136551, 2.031661674822431, 'UPHENO:0068442', 'increased level of nitrogen molecular entity in blood'),
(460243, 'HP:0003334', 'Elevated circulating catecholamine level', 'MP:0030638', 'increased circulating taurine level', 0.4125, 9.97294124817027, 2.028259910581047, 'UPHENO:0082534', 'increased bodily fluid base level'),
(460244, 'HP:0003334', 'Elevated circulating catecholamine level', 'MP:0005309', 'increased circulating ammonia level', 0.4166666666666667, 9.97294124817027, 2.03847790930822, 'UPHENO:0082534', 'increased bodily fluid base level'),
(460245, 'HP:0003334', 'Elevated circulating catecholamine level', 'MP:0011612', 'increased circulating ghrelin level', 0.4583333333333333, 10.169741955603977, 2.1589654303975836, 'UPHENO:0076293', 'abnormal hormone blood level'),
(460246, 'HP:0003334', 'Elevated circulating catecholamine level', 'MP:0005553', 'increased circulating creatinine level', 0.40789473684210525, 9.963291078136551, 2.0159300564250247, 'UPHENO:0068442', 'increased level of nitrogen molecular entity in blood'),
(460247, 'HP:0003334', 'Elevated circulating catecholamine level', 'MP:0030760', 'increased circulating dopamine level', 0.5070422535211268, 15.607147267911275, 2.813091381693426, 'UPHENO:0068363', 'increased level of catecholamine in blood'),
(460248, 'HP:0003334', 'Elevated circulating catecholamine level', 'MP:0001754', 'increased circulating corticotropin-releasing hormone level', 0.41333333333333333, 9.97294124817027, 2.030307624288426, 'UPHENO:0082534', 'increased bodily fluid base level'),
(460249, 'HP:0003334', 'Elevated circulating catecholamine level', 'MP:0030653', 'increased circulating glutathione level', 0.4024390243902439, 9.97294124817027, 2.0033723433787505, 'UPHENO:0082534', 'increased bodily fluid base level'),
(460250, 'HP:0003334', 'Elevated circulating catecholamine level', 'MP:0005610', 'increased circulating antidiuretic hormone level', 0.4714285714285714, 10.169741955603977, 2.189590583174761, 'UPHENO:0076293', 'abnormal hormone blood level'),
(460251, 'HP:0003334', 'Elevated circulating catecholamine level', 'MP:0030758', 'increased circulating histamine level', 0.4189189189189189, 9.97294124817027, 2.043979883982566, 'UPHENO:0082534', 'increased bodily fluid base level'),
(460252, 'HP:0003334', 'Elevated circulating catecholamine level', 'MP:0001748', 'increased circulating adrenocorticotropin level', 0.4230769230769231, 10.169741955603977, 2.074266890991422, 'UPHENO:0076293', 'abnormal hormone blood level'),
(460253, 'HP:0003144', 'Increased serum serotonin', 'MP:0005610', 'increased circulating antidiuretic hormone level', 0.4230769230769231, 10.169741955603977, 2.074266890991422, 'UPHENO:0076293', 'abnormal hormone blood level'),
(460254, 'HP:0003144', 'Increased serum serotonin', 'MP:0011612', 'increased circulating ghrelin level', 0.43037974683544306, 10.169741955603977, 2.0920924855834224, 'UPHENO:0076293', 'abnormal hormone blood level'),
(460255, 'HP:0012133', 'Erythroid hypoplasia', 'MP:0011182', 'decreased hematopoietic cell number', 0.4489795918367347, 9.892901750245153, 2.1075367114017225, 'UPHENO:0085371', 'abnormally decreased number of hematopoietic cell'),
(460256, 'HP:0012133', 'Erythroid hypoplasia', 'MP:0013706', 'absent megakaryocyte-erythroid progenitor cells', 0.40625, 12.237913458245556, 2.2297202385977166, 'UPHENO:0086009', 'abnormal number of anatomical enitites of type hematopoietic precursor cell'),
(460257, 'HP:0012133', 'Erythroid hypoplasia', 'MP:0008941', 'reticulocytopenia', 0.43333333333333335, 11.533898285880637, 2.2356257715790173, 'UPHENO:0085344', 'abnormally decreased number of myeloid cell'),
(460258, 'HP:0012133', 'Erythroid hypoplasia', 'MP:0013705', 'decreased megakaryocyte-erythroid progenitor cell number', 0.4262295081967213, 12.237913458245556, 2.283891379786272, 'UPHENO:0086009', 'abnormal number of anatomical enitites of type hematopoietic precursor cell'),
(460259, 'HP:0012133', 'Erythroid hypoplasia', 'MP:0008973', 'decreased erythroid progenitor cell number', 0.4393939393939394, 16.19210976863243, 2.6673422911839593, 'UPHENO:0085341', 'abnormally decreased number of erythroid progenitor cell'),
(460260, 'HP:0012133', 'Erythroid hypoplasia', 'MP:0000216', 'absent erythroid progenitor cell', 0.43283582089552236, 16.19210976863243, 2.647361917784651, 'UPHENO:0085341', 'abnormally decreased number of erythroid progenitor cell'),
(460261, 'HP:0012133', 'Erythroid hypoplasia', 'MP:0013662', 'decreased myeloid cell number', 0.4807692307692308, 11.533898285880637, 2.354812817757153, 'UPHENO:0085344', 'abnormally decreased number of myeloid cell'),
(460262, 'HP:0012133', 'Erythroid hypoplasia', 'MP:0002594', 'low mean erythrocyte cell number', 0.4090909090909091, 11.533898285880637, 2.172190814623105, 'UPHENO:0085344', 'abnormally decreased number of myeloid cell'),
(460263, 'HP:0012133', 'Erythroid hypoplasia', 'MP:0004810', 'decreased hematopoietic stem cell number', 0.4107142857142857, 12.237913458245556, 2.24193797519837, 'UPHENO:0086009', 'abnormal number of anatomical enitites of type hematopoietic precursor cell'),
(460264, 'HP:0012133', 'Erythroid hypoplasia', 'MP:0013661', 'abnormal myeloid cell number', 0.42, 10.175301480945878, 2.0672751684275776, 'UPHENO:0086005', 'abnormal number of anatomical enitites of type myeloid cell'),
(460265, 'HP:0012133', 'Erythroid hypoplasia', 'MP:0002875', 'decreased erythrocyte cell number', 0.4153846153846154, 11.533898285880637, 2.1888361983862117, 'UPHENO:0085344', 'abnormally decreased number of myeloid cell'),
(460266, 'HP:0200005', 'Abnormal shape of the palpebral fissure', 'MP:0030074', 'coarse facial features', 0.4230769230769231, 6.5236679405794336, 1.6613287933085112, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(460267, 'HP:0200005', 'Abnormal shape of the palpebral fissure', 'MP:0011495', 'abnormal head shape', 0.40816326530612246, 6.5236679405794336, 1.6317847923055813, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(460268, 'HP:0200005', 'Abnormal shape of the palpebral fissure', 'MP:0006166', 'eyelid retraction', 0.42592592592592593, 13.33412877350486, 2.3831389267666685, 'UPHENO:0003085', 'abnormal palpebral fissure'),
(460269, 'HP:0200005', 'Abnormal shape of the palpebral fissure', 'MP:0006164', 'ectropion', 0.4074074074074074, 10.404207209241001, 2.05882274255127, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(460270, 'HP:0200005', 'Abnormal shape of the palpebral fissure', 'MP:0030045', 'abnormal forehead shape', 0.41509433962264153, 6.5236679405794336, 1.6455812455519228, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(460271, 'HP:0200005', 'Abnormal shape of the palpebral fissure', 'MP:0003671', 'abnormal eyelid aperture', 0.4339622641509434, 13.33412877350486, 2.405516309034385, 'UPHENO:0003085', 'abnormal palpebral fissure'),
(460272, 'HP:0200005', 'Abnormal shape of the palpebral fissure', 'MP:0030071', 'abnormal face shape', 0.43137254901960786, 6.5236679405794336, 1.677537262920036, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(460273, 'HP:0007039', 'Symmetric lesions of the basal ganglia', 'MP:0013838', 'small caudate nucleus', 0.41509433962264153, 11.237913458245558, 2.1598134793742805, 'UPHENO:0088139', 'abnormal basal ganglion morphology'),
(460274, 'HP:0007039', 'Symmetric lesions of the basal ganglia', 'MP:0030014', 'calcified brain', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(460275, 'HP:0007039', 'Symmetric lesions of the basal ganglia', 'MP:0004077', 'abnormal striatum morphology', 0.4090909090909091, 11.237913458245558, 2.1441381095719176, 'UPHENO:0088139', 'abnormal basal ganglion morphology'),
(460276, 'HP:0007039', 'Symmetric lesions of the basal ganglia', 'MP:0000791', 'delaminated cerebral cortex', 0.4166666666666667, 8.100674382308824, 1.8371937820025075, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(460277, 'HP:0007039', 'Symmetric lesions of the basal ganglia', 'MP:0012468', 'decreased striatum size', 0.44, 11.237913458245558, 2.2236640757155848, 'UPHENO:0088139', 'abnormal basal ganglion morphology'),
(460278, 'HP:0007039', 'Symmetric lesions of the basal ganglia', 'MP:0012467', 'increased striatum size', 0.44, 11.237913458245558, 2.2236640757155848, 'UPHENO:0088139', 'abnormal basal ganglion morphology'),
(460279, 'HP:0007039', 'Symmetric lesions of the basal ganglia', 'MP:0030986', 'striatum atrophy', 0.41509433962264153, 11.237913458245558, 2.1598134793742805, 'UPHENO:0088139', 'abnormal basal ganglion morphology'),
(460280, 'HP:0007039', 'Symmetric lesions of the basal ganglia', 'MP:0012137', 'abnormal forebrain size', 0.4444444444444444, 9.371930806217245, 2.0409072934704793, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(460281, 'HP:0007039', 'Symmetric lesions of the basal ganglia', 'MP:0000771', 'abnormal brain size', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(460282, 'HP:0007039', 'Symmetric lesions of the basal ganglia', 'MP:0020541', 'abnormal substantia nigra size', 0.4117647058823529, 11.237913458245558, 2.1511336847964184, 'UPHENO:0088139', 'abnormal basal ganglion morphology'),
(460283, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0021015', 'increased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460284, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0011904', 'abnormal Schwann cell physiology', 0.4146341463414634, 7.291997705654976, 1.7388246731077175, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460285, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003471', 'abnormal summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460286, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460287, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0010050', 'hypermyelination', 0.47058823529411764, 7.291997705654976, 1.8524384826689737, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460288, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460289, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0021009', 'abnormal synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460290, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0012006', 'abnormal hippocampus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460291, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0002578', 'impaired ability to fire action potentials', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460292, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003472', 'increased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460293, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460294, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003880', 'abnormal central pattern generator function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460295, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.45454545454545453, 7.291997705654976, 1.8205890287655127, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460296, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003475', 'increased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460297, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003633', 'abnormal nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460298, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460299, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460300, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460301, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0008814', 'decreased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460302, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0013915', 'abnormal brachial plexus formation', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(460303, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0013438', 'dysmyelination', 0.47058823529411764, 7.291997705654976, 1.8524384826689737, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460304, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460305, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0014120', 'focal seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460306, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0002064', 'seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460307, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0002634', 'abnormal sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460308, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460309, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460310, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0000951', 'sporadic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460311, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0005403', 'abnormal nerve conduction', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460312, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0000947', 'convulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460313, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0005623', 'abnormal meninges morphology', 0.40625, 5.028460092616607, 1.4292697130442162, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(460314, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0011994', 'increased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460315, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460316, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003690', 'abnormal glial cell physiology', 0.41025641025641024, 7.291997705654976, 1.7296209996181215, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460317, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003465', 'increased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460318, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.45454545454545453, 7.291997705654976, 1.8205890287655127, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460319, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460320, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460321, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003480', 'increased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460322, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003470', 'abnormal summary potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460323, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460324, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460325, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460326, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003467', 'abnormal single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460327, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003466', 'decreased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460328, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460329, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003476', 'decreased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460330, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0002635', 'reduced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460331, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0000948', 'nonconvulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460332, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0012011', 'febrile seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460333, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460334, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003463', 'abnormal single cell response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460335, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003889', 'enhanced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460336, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460337, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460338, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460339, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460340, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0013806', 'encephalopathy', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460341, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003482', 'increased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460342, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460343, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003464', 'abnormal single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460344, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003473', 'decreased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460345, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0006080', 'brain ischemia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460346, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0002751', 'abnormal autonomic nervous system morphology', 0.42424242424242425, 7.61846258113911, 1.7977972728933185, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(460347, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0002752', 'abnormal somatic nervous system morphology', 0.42424242424242425, 7.61846258113911, 1.7977972728933185, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(460348, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0005402', 'abnormal action potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460349, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0000920', 'abnormal myelination', 0.48484848484848486, 7.291997705654976, 1.8802962636524712, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460350, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003474', 'abnormal summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460351, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.42857142857142855, 7.291997705654976, 1.7678070804960966, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460352, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003468', 'increased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460353, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0004994', 'abnormal brain wave pattern', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460354, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003469', 'decreased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460355, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460356, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0003477', 'abnormal nerve fiber response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460357, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0004513', 'avnosmia', 0.4411764705882353, 7.291997705654976, 1.793615848312668, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460358, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.42857142857142855, 7.291997705654976, 1.7678070804960966, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460359, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0000921', 'demyelination', 0.47058823529411764, 7.291997705654976, 1.8524384826689737, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460360, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460361, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460362, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460363, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460364, 'HP:0007141', 'Sensorimotor neuropathy', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(460365, 'HP:0002948', 'Vertebral fusion', 'MP:0004612', 'fusion of vertebral bodies', 0.4305555555555556, 13.87018167374507, 2.443743803305861, 'UPHENO:0078122', 'abnormally fused anatomical entity and bony vertebral centrum'),
(460366, 'HP:0002948', 'Vertebral fusion', 'MP:0004622', 'sacral vertebral fusion', 0.42857142857142855, 12.49167005049134, 2.313778917438311, 'UPHENO:0078067', 'abnormally fused vertebra and anatomical entity'),
(460367, 'HP:0002948', 'Vertebral fusion', 'MP:0004621', 'lumbar vertebral fusion', 0.410958904109589, 12.49167005049134, 2.2657367531221486, 'UPHENO:0078067', 'abnormally fused vertebra and anatomical entity'),
(460368, 'HP:0002948', 'Vertebral fusion', 'MP:0004613', 'fusion of vertebral arches', 0.42857142857142855, 12.49167005049134, 2.313778917438311, 'UPHENO:0078067', 'abnormally fused vertebra and anatomical entity'),
(460369, 'HP:0002948', 'Vertebral fusion', 'MP:0004609', 'vertebral fusion', 0.46875, 12.49167005049134, 2.4198079130724026, 'UPHENO:0078067', 'abnormally fused vertebra and anatomical entity'),
(460370, 'HP:0002948', 'Vertebral fusion', 'MP:0004619', 'caudal vertebral fusion', 0.410958904109589, 12.49167005049134, 2.2657367531221486, 'UPHENO:0078067', 'abnormally fused vertebra and anatomical entity'),
(460371, 'HP:0003777', 'Pili torti', 'MP:0008237', 'abnormal ventral coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460372, 'HP:0003777', 'Pili torti', 'MP:0013115', 'focal hair loss in abdominal region', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460373, 'HP:0003777', 'Pili torti', 'MP:0030584', 'skin atrophy', 0.40540540540540543, 6.904974582545727, 1.6731150647672055, 'UPHENO:0003811', 'abnormal skin of body'),
(460374, 'HP:0003777', 'Pili torti', 'MP:0001197', 'oily skin', 0.4166666666666667, 6.904974582545727, 1.6961936041405727, 'UPHENO:0003811', 'abnormal skin of body'),
(460375, 'HP:0003777', 'Pili torti', 'MP:0000407', 'abnormal duvet hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(460376, 'HP:0003777', 'Pili torti', 'MP:0004034', 'belly blaze', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460377, 'HP:0003777', 'Pili torti', 'MP:0002940', 'variable body spotting', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(460378, 'HP:0003777', 'Pili torti', 'MP:0003956', 'abnormal body size', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(460379, 'HP:0003777', 'Pili torti', 'MP:0000367', 'abnormal coat/ hair morphology', 0.4838709677419355, 9.570057949176055, 2.1518999050174754, 'UPHENO:0002768', 'abnormal strand of hair'),
(460380, 'HP:0003777', 'Pili torti', 'MP:0000405', 'abnormal auchene hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(460381, 'HP:0003777', 'Pili torti', 'MP:0020440', 'abnormal front foot hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460382, 'HP:0003777', 'Pili torti', 'MP:0009004', 'progressive hair loss', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(460383, 'HP:0003777', 'Pili torti', 'MP:0000400', 'abnormal awl hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(460384, 'HP:0003777', 'Pili torti', 'MP:0011280', 'abnormal flank coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460385, 'HP:0003777', 'Pili torti', 'MP:0000373', 'belly spot', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(460386, 'HP:0003777', 'Pili torti', 'MP:0001510', 'abnormal coat appearance', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(460387, 'HP:0003777', 'Pili torti', 'MP:0010202', 'focal dorsal hair loss', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460388, 'HP:0003777', 'Pili torti', 'MP:0013116', 'focal hair loss in head/neck region', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460389, 'HP:0003777', 'Pili torti', 'MP:0010142', 'disorganized hair shaft', 0.4186046511627907, 9.570057949176055, 2.0015171169446777, 'UPHENO:0002768', 'abnormal strand of hair'),
(460390, 'HP:0003777', 'Pili torti', 'MP:0003849', 'greasy coat', 0.4090909090909091, 9.570057949176055, 1.9786418843441866, 'UPHENO:0002768', 'abnormal strand of hair'),
(460391, 'HP:0003777', 'Pili torti', 'MP:0000397', 'abnormal guard hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(460392, 'HP:0003777', 'Pili torti', 'MP:0000402', 'abnormal zigzag hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(460393, 'HP:0003777', 'Pili torti', 'MP:0001211', 'wrinkled skin', 0.42857142857142855, 6.904974582545727, 1.7202542896592428, 'UPHENO:0003811', 'abnormal skin of body'),
(460394, 'HP:0003777', 'Pili torti', 'MP:0012017', 'grizzled coat color', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460395, 'HP:0003777', 'Pili torti', 'MP:0012076', 'abnormal agouti pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460396, 'HP:0003777', 'Pili torti', 'MP:0009934', 'abnormal hind foot hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460397, 'HP:0003777', 'Pili torti', 'MP:0009002', 'premature hair regrowth', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(460398, 'HP:0003777', 'Pili torti', 'MP:0003196', 'calcified skin', 0.4411764705882353, 6.904974582545727, 1.7453688194272856, 'UPHENO:0003811', 'abnormal skin of body'),
(460399, 'HP:0003777', 'Pili torti', 'MP:0000411', 'shiny fur', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(460400, 'HP:0003777', 'Pili torti', 'MP:0009933', 'abnormal tail hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460401, 'HP:0003777', 'Pili torti', 'MP:0001511', 'disheveled coat', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(460402, 'HP:0003777', 'Pili torti', 'MP:0005409', 'darkened coat color', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(460403, 'HP:0003777', 'Pili torti', 'MP:0000372', 'irregular coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460404, 'HP:0003777', 'Pili torti', 'MP:0008812', 'abnormal rostrocaudal coat patterning', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460405, 'HP:0003777', 'Pili torti', 'MP:0009932', 'skin fibrosis', 0.4411764705882353, 6.904974582545727, 1.7453688194272856, 'UPHENO:0003811', 'abnormal skin of body'),
(460406, 'HP:0003777', 'Pili torti', 'MP:0000426', 'ectopic hair growth', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(460407, 'HP:0003777', 'Pili torti', 'MP:0020235', 'black belted', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460408, 'HP:0003777', 'Pili torti', 'MP:0009928', 'abnormal pinna hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460409, 'HP:0003777', 'Pili torti', 'MP:0000371', 'diluted coat color', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460410, 'HP:0003777', 'Pili torti', 'MP:0000370', 'head blaze', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460411, 'HP:0003777', 'Pili torti', 'MP:0002938', 'white spotting', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460412, 'HP:0003777', 'Pili torti', 'MP:0002073', 'abnormal hair growth', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(460413, 'HP:0003777', 'Pili torti', 'MP:0002671', 'belted', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460414, 'HP:0003777', 'Pili torti', 'MP:0002075', 'abnormal coat/hair pigmentation', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(460415, 'HP:0003777', 'Pili torti', 'MP:0008899', 'plush coat', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(460416, 'HP:0003777', 'Pili torti', 'MP:0000418', 'focal hair loss', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(460417, 'HP:0003777', 'Pili torti', 'MP:0005366', 'variegated coat color', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(460418, 'HP:0003777', 'Pili torti', 'MP:0013117', 'focal hair loss in thorax region', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460419, 'HP:0003777', 'Pili torti', 'MP:0005114', 'premature hair loss', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(460420, 'HP:0003777', 'Pili torti', 'MP:0005171', 'absent coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460421, 'HP:0003777', 'Pili torti', 'MP:0010203', 'focal ventral hair loss', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460422, 'HP:0003777', 'Pili torti', 'MP:0008238', 'abnormal dorsoventral coat patterning', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(460423, 'HP:0003777', 'Pili torti', 'MP:0009659', 'striated fur', 0.41025641025641024, 9.570057949176055, 1.9814584578473484, 'UPHENO:0002768', 'abnormal strand of hair'),
(460424, 'HP:0020036', 'Upper limb dysmetria', 'MP:0003158', 'dysphagia', 0.4074074074074074, 10.749166272783702, 2.092675312365956, 'UPHENO:0074360', 'abnormally decreased rate of behavior process'),
(460425, 'HP:0030541', 'Unaided visual acuity 0.6 LogMAR', 'MP:0005551', 'abnormal eye electrophysiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(460426, 'HP:0030541', 'Unaided visual acuity 0.6 LogMAR', 'MP:0014132', 'abnormal tear film physiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(460427, 'HP:0030541', 'Unaided visual acuity 0.6 LogMAR', 'MP:0013145', 'eye discharge', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(460428, 'HP:0030541', 'Unaided visual acuity 0.6 LogMAR', 'MP:0020218', 'abnormal tear production', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(460429, 'HP:0030541', 'Unaided visual acuity 0.6 LogMAR', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(460430, 'HP:0030541', 'Unaided visual acuity 0.6 LogMAR', 'MP:0003011', 'delayed dark adaptation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(460431, 'HP:0030541', 'Unaided visual acuity 0.6 LogMAR', 'MP:0020860', 'abnormal cornea physiology', 0.4186046511627907, 8.795504987450572, 1.9188119493770963, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(460432, 'HP:0030541', 'Unaided visual acuity 0.6 LogMAR', 'MP:0001337', 'dry eyes', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(460433, 'HP:0030541', 'Unaided visual acuity 0.6 LogMAR', 'MP:0006190', 'retina ischemia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(460434, 'HP:0030541', 'Unaided visual acuity 0.6 LogMAR', 'MP:0003096', 'increased corneal light-scattering', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(460435, 'HP:0030541', 'Unaided visual acuity 0.6 LogMAR', 'MP:0005253', 'abnormal eye physiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(460436, 'HP:0030541', 'Unaided visual acuity 0.6 LogMAR', 'MP:0002090', 'abnormal vision', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(460437, 'HP:0009794', 'Branchial anomaly', 'MP:0003935', 'abnormal craniofacial development', 0.43478260869565216, 3.8548363184545034, 1.294610285233511, 'UPHENO:0002764', 'abnormal craniocervical region'),
(460438, 'HP:0009794', 'Branchial anomaly', 'MP:0005499', 'abnormal olfactory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460439, 'HP:0009794', 'Branchial anomaly', 'MP:0002111', 'abnormal tail morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460440, 'HP:0009794', 'Branchial anomaly', 'MP:0005500', 'abnormal gustatory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460441, 'HP:0009794', 'Branchial anomaly', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460442, 'HP:0009794', 'Branchial anomaly', 'MP:0012719', 'abnormal neck morphology', 0.44, 10.533898285880637, 2.1528853303851276, 'UPHENO:0003074', 'abnormal neck'),
(460443, 'HP:0009794', 'Branchial anomaly', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460444, 'HP:0009794', 'Branchial anomaly', 'MP:0012723', 'abnormal nuchal region morphology', 0.4074074074074074, 10.533898285880637, 2.0716148750537497, 'UPHENO:0003074', 'abnormal neck'),
(460445, 'HP:0009794', 'Branchial anomaly', 'MP:0014134', 'abnormal embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460446, 'HP:0009794', 'Branchial anomaly', 'MP:0002163', 'abnormal gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460447, 'HP:0009794', 'Branchial anomaly', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460448, 'HP:0009794', 'Branchial anomaly', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460449, 'HP:0009794', 'Branchial anomaly', 'MP:0000428', 'abnormal craniofacial morphology', 0.45454545454545453, 3.8548363184545034, 1.3237062841016616, 'UPHENO:0002764', 'abnormal craniocervical region'),
(460450, 'HP:0009794', 'Branchial anomaly', 'MP:0003385', 'abnormal body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460451, 'HP:0010931', 'Abnormal blood sodium concentration', 'MP:0003018', 'abnormal circulating chloride level', 0.43478260869565216, 12.062826751687464, 2.2901325907777426, 'UPHENO:0051960', 'abnormal blood monoatomic ion level'),
(460452, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0011364', 'abnormal metanephros morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460453, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0003613', 'abnormal kidney medulla development', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460454, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0000527', 'abnormal kidney development', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460455, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460456, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460457, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0003881', 'abnormal nephron morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460458, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0004195', 'abnormal kidney calyx morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460459, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0011402', 'renal cast', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460460, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0011347', 'abnormal kidney medullary ray morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460461, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0000521', 'abnormal kidney cortex morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460462, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0011382', 'abnormal kidney lobule morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460463, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0011383', 'abnormal kidney capsule morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460464, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460465, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0012024', 'abnormal nephron morphogenesis', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460466, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0002829', 'abnormal juxtaglomerular apparatus morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460467, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0009860', 'nephrosclerosis', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460468, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0003014', 'abnormal kidney medulla morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460469, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0004192', 'abnormal kidney pyramid morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460470, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0011333', 'abnormal kidney inner medulla morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460471, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0011332', 'abnormal kidney outer medulla morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460472, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460473, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0004969', 'pale kidney', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460474, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0011534', 'granular kidney', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460475, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0011381', 'abnormal kidney lobe morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460476, 'HP:0033974', 'Interlobular vein intima/media multilamellation', 'MP:0002135', 'abnormal kidney morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(460477, 'HP:0030804', 'Trachyonychia', 'MP:0012404', 'abnormal nail color', 0.4090909090909091, 11.192109768632431, 2.13976408977604, 'UPHENO:0088109', 'abnormal nail morphology'),
(460478, 'HP:0001922', 'Vacuolated lymphocytes', 'MP:0000716', 'abnormal immune system cell morphology', 0.4444444444444444, 7.198463708615836, 1.7886635244867213, 'UPHENO:0087123', 'abnormal immune system morphology'),
(460479, 'HP:0001922', 'Vacuolated lymphocytes', 'MP:0012360', 'abnormal large unstained cell number', 0.43243243243243246, 7.198463708615836, 1.7643268323338888, 'UPHENO:0087123', 'abnormal immune system morphology'),
(460480, 'HP:0001922', 'Vacuolated lymphocytes', 'MP:0008246', 'abnormal leukocyte morphology', 0.4090909090909091, 8.464189314069232, 1.8608124304212235, 'UPHENO:0088166', 'abnormal leukocyte morphology'),
(460481, 'HP:0001922', 'Vacuolated lymphocytes', 'MP:0000358', 'abnormal cell morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(460482, 'HP:0001922', 'Vacuolated lymphocytes', 'MP:0008199', 'increased follicular dendritic cell number', 0.41025641025641024, 7.198463708615836, 1.7184923277273538, 'UPHENO:0087123', 'abnormal immune system morphology'),
(460483, 'HP:0001922', 'Vacuolated lymphocytes', 'MP:0008196', 'abnormal follicular dendritic cell morphology', 0.42105263157894735, 7.198463708615836, 1.7409572332019665, 'UPHENO:0087123', 'abnormal immune system morphology'),
(460484, 'HP:0034547', 'Intraluminal meconium calcification', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460485, 'HP:0034547', 'Intraluminal meconium calcification', 'MP:0003385', 'abnormal body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460486, 'HP:0034547', 'Intraluminal meconium calcification', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460487, 'HP:0034547', 'Intraluminal meconium calcification', 'MP:0002163', 'abnormal gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460488, 'HP:0034547', 'Intraluminal meconium calcification', 'MP:0005500', 'abnormal gustatory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460489, 'HP:0034547', 'Intraluminal meconium calcification', 'MP:0005499', 'abnormal olfactory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460490, 'HP:0034547', 'Intraluminal meconium calcification', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460491, 'HP:0034547', 'Intraluminal meconium calcification', 'MP:0014134', 'abnormal embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460492, 'HP:0034547', 'Intraluminal meconium calcification', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460493, 'HP:0034547', 'Intraluminal meconium calcification', 'MP:0002111', 'abnormal tail morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(460494, 'HP:0500093', 'Food allergy', 'MP:0005001', 'abnormal clonal deletion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460495, 'HP:0500093', 'Food allergy', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460496, 'HP:0500093', 'Food allergy', 'MP:0001790', 'abnormal immune system physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460497, 'HP:0500093', 'Food allergy', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460498, 'HP:0500093', 'Food allergy', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460499, 'HP:0500093', 'Food allergy', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460500, 'HP:0500093', 'Food allergy', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460501, 'HP:0500093', 'Food allergy', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460502, 'HP:0500093', 'Food allergy', 'MP:0000392', 'accelerated hair follicle regression', 0.43243243243243246, 8.297292005324488, 1.8942064735568411, 'UPHENO:0054970', 'increased biological_process'),
(460503, 'HP:0500093', 'Food allergy', 'MP:0002498', 'abnormal acute inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460504, 'HP:0500093', 'Food allergy', 'MP:0002499', 'chronic inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460505, 'HP:0500093', 'Food allergy', 'MP:0020001', 'decreased response to antigen', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460506, 'HP:0500093', 'Food allergy', 'MP:0020000', 'abnormal response to antigen', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460507, 'HP:0500093', 'Food allergy', 'MP:0001846', 'increased inflammatory response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460508, 'HP:0500093', 'Food allergy', 'MP:0001845', 'abnormal inflammatory response', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460509, 'HP:0500093', 'Food allergy', 'MP:0001876', 'decreased inflammatory response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460510, 'HP:0500093', 'Food allergy', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460511, 'HP:0500093', 'Food allergy', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460512, 'HP:0500093', 'Food allergy', 'MP:0020002', 'increased response to antigen', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460513, 'HP:0500093', 'Food allergy', 'MP:0004751', 'increased length of allograft survival', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460514, 'HP:0500093', 'Food allergy', 'MP:0005000', 'abnormal immune tolerance', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460515, 'HP:0500093', 'Food allergy', 'MP:0005004', 'abnormal lymphocyte anergy', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460516, 'HP:0500093', 'Food allergy', 'MP:0002420', 'abnormal adaptive immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460517, 'HP:0500093', 'Food allergy', 'MP:0020154', 'impaired humoral immune response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460518, 'HP:0500093', 'Food allergy', 'MP:0005025', 'abnormal response to infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460519, 'HP:0500093', 'Food allergy', 'MP:0005005', 'abnormal self tolerance', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460520, 'HP:0500093', 'Food allergy', 'MP:0004752', 'decreased length of allograft survival', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460521, 'HP:0500093', 'Food allergy', 'MP:0003009', 'abnormal cytokine secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460522, 'HP:0500093', 'Food allergy', 'MP:0002419', 'abnormal innate immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460523, 'HP:0500093', 'Food allergy', 'MP:0020155', 'enhanced humoral immune response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460524, 'HP:0500093', 'Food allergy', 'MP:0001800', 'abnormal humoral immune response', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460525, 'HP:0500093', 'Food allergy', 'MP:0001835', 'abnormal antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460526, 'HP:0500093', 'Food allergy', 'MP:0005671', 'abnormal response to transplant', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460527, 'HP:0500093', 'Food allergy', 'MP:0003762', 'abnormal immune organ physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460528, 'HP:0032363', 'Decreased circulating corticosterone level', 'MP:0002665', 'decreased circulating corticosterone level', 0.5857142857142857, 16.607147267911277, 3.1188208348311073, 'UPHENO:0034326', 'decreased level of corticosterone in blood'),
(460529, 'HP:0032363', 'Decreased circulating corticosterone level', 'MP:0003458', 'decreased circulating ketone body level', 0.42028985507246375, 11.92532322793753, 2.238770281016378, 'UPHENO:0034466', 'decreased level of lipid in blood'),
(460530, 'HP:0032363', 'Decreased circulating corticosterone level', 'MP:0002780', 'decreased circulating testosterone level', 0.41025641025641024, 11.92532322793753, 2.211886140523747, 'UPHENO:0034466', 'decreased level of lipid in blood'),
(460531, 'HP:0032363', 'Decreased circulating corticosterone level', 'MP:0002667', 'decreased circulating aldosterone level', 0.4050632911392405, 11.92532322793753, 2.1978422770088866, 'UPHENO:0034466', 'decreased level of lipid in blood'),
(460532, 'HP:0032363', 'Decreased circulating corticosterone level', 'MP:0005185', 'decreased circulating progesterone level', 0.4383561643835616, 11.92532322793753, 2.28638119071009, 'UPHENO:0034466', 'decreased level of lipid in blood'),
(460533, 'HP:0032363', 'Decreased circulating corticosterone level', 'MP:0005181', 'decreased circulating estradiol level', 0.4266666666666667, 11.92532322793753, 2.2556901184752043, 'UPHENO:0034466', 'decreased level of lipid in blood'),
(460534, 'HP:0032363', 'Decreased circulating corticosterone level', 'MP:0003368', 'decreased circulating glucocorticoid level', 0.5223880597014925, 15.384754846574829, 2.834927200702931, 'UPHENO:0034213', 'decreased level of glucocorticoid in blood'),
(460535, 'HP:0032363', 'Decreased circulating corticosterone level', 'MP:0005345', 'abnormal circulating corticosterone level', 0.4117647058823529, 14.491670050491338, 2.442776751175733, 'UPHENO:0051784', 'abnormal blood corticosterone level'),
(460536, 'HP:0032363', 'Decreased circulating corticosterone level', 'MP:0003374', 'decreased circulating mineralocorticoid level', 0.43661971830985913, 11.92532322793753, 2.2818482132990585, 'UPHENO:0034466', 'decreased level of lipid in blood'),
(460537, 'HP:0032363', 'Decreased circulating corticosterone level', 'MP:0003510', 'decreased circulating dihydrotestosterone level', 0.42105263157894735, 11.92532322793753, 2.240800912074217, 'UPHENO:0034466', 'decreased level of lipid in blood'),
(460538, 'HP:0030251', 'Absence of memory B cells', 'MP:0008174', 'decreased follicular B cell number', 0.4077669902912621, 12.285219173023913, 2.2381927636493844, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460539, 'HP:0030251', 'Absence of memory B cells', 'MP:0000238', 'absent pre-B cells', 0.4158415841584158, 12.285219173023913, 2.2602444563904163, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460540, 'HP:0030251', 'Absence of memory B cells', 'MP:0008347', 'decreased gamma-delta T cell number', 0.40625, 10.66072830811612, 2.0810864650879295, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460541, 'HP:0030251', 'Absence of memory B cells', 'MP:0008083', 'decreased single-positive T cell number', 0.4148936170212766, 10.66072830811612, 2.103109157375197, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460542, 'HP:0030251', 'Absence of memory B cells', 'MP:0008207', 'decreased B-2 B cell number', 0.42424242424242425, 12.285219173023913, 2.2829610518607573, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460543, 'HP:0030251', 'Absence of memory B cells', 'MP:0013768', 'decreased marginal zone precursor B cell number', 0.45652173913043476, 12.285219173023913, 2.368220771479601, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460544, 'HP:0030251', 'Absence of memory B cells', 'MP:0012768', 'decreased KLRG1-positive NK cell number', 0.42391304347826086, 10.66072830811612, 2.125846133375686, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460545, 'HP:0030251', 'Absence of memory B cells', 'MP:0004974', 'decreased regulatory T cell number', 0.40625, 10.66072830811612, 2.0810864650879295, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460546, 'HP:0030251', 'Absence of memory B cells', 'MP:0008209', 'decreased pre-B cell number', 0.4666666666666667, 12.285219173023913, 2.3943897512193986, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460547, 'HP:0030251', 'Absence of memory B cells', 'MP:0005018', 'decreased T cell number', 0.43333333333333335, 10.66072830811612, 2.1493368590141904, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460548, 'HP:0030251', 'Absence of memory B cells', 'MP:0012765', 'decreased alpha-beta T cell number', 0.40625, 10.66072830811612, 2.0810864650879295, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460549, 'HP:0030251', 'Absence of memory B cells', 'MP:0012361', 'decreased large unstained cell number', 0.45348837209302323, 10.66072830811612, 2.1987533571943874, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460550, 'HP:0030251', 'Absence of memory B cells', 'MP:0008050', 'decreased memory T cell number', 0.40625, 10.66072830811612, 2.0810864650879295, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460551, 'HP:0030251', 'Absence of memory B cells', 'MP:0013276', 'absent alpha-beta T cells', 0.4020618556701031, 10.66072830811612, 2.0703314242787227, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460552, 'HP:0030251', 'Absence of memory B cells', 'MP:0013685', 'decreased late germinal center B cell number', 0.4174757281553398, 12.285219173023913, 2.264681173985888, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460553, 'HP:0030251', 'Absence of memory B cells', 'MP:0004978', 'decreased B-1 B cell number', 0.4158415841584158, 12.285219173023913, 2.2602444563904163, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460554, 'HP:0030251', 'Absence of memory B cells', 'MP:0005017', 'decreased B cell number', 0.4827586206896552, 12.285219173023913, 2.435322455618379, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460555, 'HP:0030251', 'Absence of memory B cells', 'MP:0013672', 'decreased mature NK cell number', 0.40625, 10.66072830811612, 2.0810864650879295, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460556, 'HP:0030251', 'Absence of memory B cells', 'MP:0008185', 'decreased naive B cell number', 0.42424242424242425, 12.285219173023913, 2.2829610518607573, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460557, 'HP:0030251', 'Absence of memory B cells', 'MP:0008212', 'absent mature B cells', 0.4158415841584158, 12.285219173023913, 2.2602444563904163, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460558, 'HP:0030251', 'Absence of memory B cells', 'MP:0005016', 'decreased lymphocyte cell number', 0.4642857142857143, 10.66072830811612, 2.224775012746149, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460559, 'HP:0030251', 'Absence of memory B cells', 'MP:0013666', 'decreased immature NK cell number', 0.40625, 10.66072830811612, 2.0810864650879295, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460560, 'HP:0030251', 'Absence of memory B cells', 'MP:0008729', 'decreased memory B cell number', 0.4158415841584158, 12.285219173023913, 2.2602444563904163, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460561, 'HP:0030251', 'Absence of memory B cells', 'MP:0008071', 'absent B cells', 0.4421052631578947, 12.285219173023913, 2.3305278491024626, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460562, 'HP:0030251', 'Absence of memory B cells', 'MP:0008098', 'decreased plasma cell number', 0.4329896907216495, 12.285219173023913, 2.306376649677, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460563, 'HP:0030251', 'Absence of memory B cells', 'MP:0008178', 'decreased germinal center B cell number', 0.42574257425742573, 12.285219173023913, 2.2869938425889744, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460564, 'HP:0030251', 'Absence of memory B cells', 'MP:0008211', 'decreased mature B cell number', 0.46153846153846156, 12.285219173023913, 2.381197420790697, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460565, 'HP:0030251', 'Absence of memory B cells', 'MP:0013426', 'decreased memory-marker NK cell number', 0.42391304347826086, 10.66072830811612, 2.125846133375686, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460566, 'HP:0030251', 'Absence of memory B cells', 'MP:0013683', 'decreased early germinal center B cell number', 0.4174757281553398, 12.285219173023913, 2.264681173985888, 'UPHENO:0085305', 'abnormally decreased number of B cell'),
(460567, 'HP:0030251', 'Absence of memory B cells', 'MP:0008045', 'decreased NK cell number', 0.43333333333333335, 10.66072830811612, 2.1493368590141904, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460568, 'HP:0030251', 'Absence of memory B cells', 'MP:0000221', 'decreased leukocyte cell number', 0.4125, 10.255471829629862, 2.0567892769368274, 'UPHENO:0085330', 'abnormally decreased number of leukocyte'),
(460569, 'HP:0030251', 'Absence of memory B cells', 'MP:0000726', 'absent lymphocyte', 0.43333333333333335, 10.66072830811612, 2.1493368590141904, 'UPHENO:0088341', 'abnormally decreased number of lymphocyte in the independent continuant'),
(460570, 'HP:0003137', 'Prolinuria', 'MP:0030689', 'cystathioninuria', 0.4823529411764706, 11.226325483970346, 2.3270262387427993, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460571, 'HP:0003137', 'Prolinuria', 'MP:0011654', 'histidinuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460572, 'HP:0003137', 'Prolinuria', 'MP:0030620', 'valinuria', 0.47674418604651164, 11.226325483970346, 2.3134574569567197, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460573, 'HP:0003137', 'Prolinuria', 'MP:0020402', 'ornithinuria', 0.4823529411764706, 11.226325483970346, 2.3270262387427993, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460574, 'HP:0003137', 'Prolinuria', 'MP:0011470', 'increased urine creatinine level', 0.4177215189873418, 11.094077685671904, 2.1527273358747596, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(460575, 'HP:0003137', 'Prolinuria', 'MP:0030613', 'dicarboxylic aciduria', 0.42105263157894735, 10.47786425096631, 2.1004124157403803, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(460576, 'HP:0003137', 'Prolinuria', 'MP:0030616', 'hyperglycinuria', 0.5058823529411764, 12.982656403003482, 2.5627517961320856, 'UPHENO:0080641', 'increased level of proteinogenic amino acid in urine'),
(460577, 'HP:0003137', 'Prolinuria', 'MP:0003311', 'aminoaciduria', 0.5263157894736842, 11.226325483970346, 2.4307596261219233, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460578, 'HP:0003137', 'Prolinuria', 'MP:0020404', 'prolinuria', 0.5822784810126582, 16.607147267911277, 3.1096598664665716, 'UPHENO:0068019', 'increased level of proline in urine'),
(460579, 'HP:0003137', 'Prolinuria', 'MP:0030617', 'hyperglutaminuria', 0.4880952380952381, 11.226325483970346, 2.3408366047277083, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460580, 'HP:0003137', 'Prolinuria', 'MP:0020403', 'lysinuria', 0.47674418604651164, 11.226325483970346, 2.3134574569567197, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460581, 'HP:0003137', 'Prolinuria', 'MP:0011516', 'aspartylglucosaminuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460582, 'HP:0003137', 'Prolinuria', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.4823529411764706, 11.226325483970346, 2.3270262387427993, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460583, 'HP:0003137', 'Prolinuria', 'MP:0020401', 'argininuria', 0.4880952380952381, 11.226325483970346, 2.3408366047277083, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460584, 'HP:0003137', 'Prolinuria', 'MP:0013730', 'glutathionuria', 0.47126436781609193, 11.226325483970346, 2.3001232971519086, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460585, 'HP:0003137', 'Prolinuria', 'MP:0020405', 'taurinuria', 0.4880952380952381, 11.226325483970346, 2.3408366047277083, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460586, 'HP:0003137', 'Prolinuria', 'MP:0020406', 'hyperthreoninuria', 0.4880952380952381, 11.226325483970346, 2.3408366047277083, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460587, 'HP:0003137', 'Prolinuria', 'MP:0011765', 'oroticaciduria', 0.4605263157894737, 10.47786425096631, 2.1966638843573105, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(460588, 'HP:0003137', 'Prolinuria', 'MP:0020400', 'cystinuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460589, 'HP:0003137', 'Prolinuria', 'MP:0030618', 'tryptophanuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460590, 'HP:0003137', 'Prolinuria', 'MP:0030682', 'hydroxyprolinuria', 0.45977011494252873, 11.226325483970346, 2.271899856540179, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(460591, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012565', 'perivasculitis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460592, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010141', 'lymphangitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460593, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460594, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001835', 'abnormal antigen presentation', 0.6086956521739131, 7.400946880077414, 2.122480668433333, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460595, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003298', 'choking', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460596, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011920', 'abnormal S wave', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460597, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002410', 'decreased susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460598, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001872', 'sinus inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460599, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001846', 'increased inflammatory response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460600, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460601, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005190', 'osteomyelitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460602, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010552', 'abnormal HV interval', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460603, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020040', 'decreased bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460604, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012111', 'failure of morula compaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460605, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006229', 'iris inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460606, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031480', 'abnormal urine xanthine level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460607, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460608, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012035', 'abnormal b-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460609, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460610, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012555', 'decreased cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460611, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000501', 'abnormal digestive secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460612, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014043', 'decreased cellular sensitivity to cisplatin', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460613, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460614, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002335', 'decreased airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460615, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002634', 'abnormal sensorimotor gating', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460616, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012746', 'abnormal neural crest cell delamination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460617, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011717', 'increased interleukin-8 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460618, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030991', 'optic nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460619, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001951', 'abnormal breathing pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460620, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460621, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011927', 'abnormal cardiac valve flow', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460622, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011164', 'panniculitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460623, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460624, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001840', 'increased level of surface class I molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460625, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031479', 'increased urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460626, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001596', 'hypotension', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460627, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0021015', 'increased tau protein phosphorylation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460628, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004036', 'abnormal muscle relaxation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460629, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008709', 'decreased interleukin-7 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460630, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460631, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020002', 'increased response to antigen', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460632, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011044', 'increased lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460633, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004766', 'decreased susceptibility to age-related hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460634, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031226', 'increased CXCL10 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460635, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030215', 'facial muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460636, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460637, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0021010', 'impaired synaptic physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460638, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004149', 'increased bone strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460639, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030988', 'dysosmia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460640, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460641, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460642, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011566', 'abnormal complement protein level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460643, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010510', 'absent P wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460644, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460645, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013557', 'abnormal merocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460646, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008702', 'increased interleukin-5 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460647, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003865', 'lymph node inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460648, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031402', 'decreased muscle fatigability', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460649, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013478', 'corneal limbitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460650, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008145', 'hemeralopia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460651, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013136', 'genital discharge', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460652, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008008', 'early cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460653, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008690', 'increased interleukin-23 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460654, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460655, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460656, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002500', 'granulomatous inflammation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460657, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001950', 'abnormal respiratory sounds', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460658, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010559', 'heart block', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460659, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460660, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004812', 'abnormal linear vestibular evoked potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460661, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020219', 'increased tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460662, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010896', 'decreased lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460663, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002471', 'abnormal complement pathway', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460664, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001983', 'abnormal olfactory system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460665, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003216', 'absence seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460666, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004877', 'abnormal systemic vascular resistance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460667, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460668, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031424', 'enhanced female fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460669, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008403', 'decreased cellular sensitivity to alkylating agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460670, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003621', 'dysuria', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460671, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002334', 'abnormal airway responsiveness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460672, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460673, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009792', 'seborrheic dermatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460674, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460675, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460676, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011926', 'abnormal heart valve physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460677, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031125', 'aspiration pneumonia', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460678, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000064', 'failure of bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460679, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001933', 'abnormal litter size', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460680, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460681, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013467', 'diaphragmitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460682, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005085', 'abnormal gallbladder physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460683, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460684, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005647', 'abnormal sex gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460685, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014029', 'increased respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460686, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031484', 'increased urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460687, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460688, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010637', 'sinus bradycardia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460689, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460690, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012011', 'febrile seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460691, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460692, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008568', 'abnormal interleukin secretion', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460693, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002907', 'abnormal parturition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460694, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002723', 'abnormal immune serum protein physiology', 0.6086956521739131, 7.400946880077414, 2.122480668433333, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460695, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012201', 'decreased endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460696, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460697, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005330', 'cardiomyopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460698, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460699, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001919', 'abnormal reproductive system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460700, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020414', 'abnormal fibroblast physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460701, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004773', 'abnormal bile composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460702, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003746', 'stomatitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460703, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003566', 'abnormal cell adhesion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460704, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014182', 'decreased respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460705, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460706, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010516', 'absent Q wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460707, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460708, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460709, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012197', 'impaired myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460710, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460711, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003252', 'abnormal bile duct physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460712, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013479', 'scleritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460713, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006049', 'semilunar valve regurgitation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460714, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460715, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460716, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001934', 'increased litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460717, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001853', 'heart inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460718, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010519', 'atrioventricular block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460719, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010028', 'aciduria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460720, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460721, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460722, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020138', 'delayed bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460723, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460724, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008943', 'increased sensitivity to induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460725, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460726, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012006', 'abnormal hippocampus physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460727, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460728, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460729, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013134', 'poor circulation in autopods', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460730, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460731, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020155', 'enhanced humoral immune response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460732, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.6086956521739131, 7.400946880077414, 2.122480668433333, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460733, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004780', 'abnormal surfactant secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460734, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031091', 'hypogeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460735, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031483', 'decreased urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460736, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460737, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002136', 'abnormal kidney physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460738, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011295', 'abnormal tubuloglomerular feedback response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460739, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460740, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008055', 'increased urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460741, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006045', 'mitral valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460742, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031241', 'decreased CSF3 level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460743, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008564', 'increased interferon-beta secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460744, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012124', 'increased bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460745, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011764', 'ureteritis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460746, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008681', 'increased interleukin-17 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460747, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010553', 'prolonged HV interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460748, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003635', 'abnormal synaptic transmission', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460749, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030904', 'abnormal melanoblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460750, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013555', 'abnormal apocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460751, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014183', 'increased respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460752, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003929', 'decreased heart rate variability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460753, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008672', 'increased interleukin-13 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460754, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003889', 'enhanced sensorimotor gating', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460755, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010386', 'abnormal urinary bladder physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460756, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011397', 'endoneurial edema', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460757, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011518', 'abnormal cell chemotaxis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460758, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031104', 'crackles', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460759, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001800', 'abnormal humoral immune response', 0.6086956521739131, 7.400946880077414, 2.122480668433333, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460760, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001856', 'myocarditis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460761, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008675', 'increased interleukin-15 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460762, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003472', 'increased summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460763, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008555', 'abnormal interferon secretion', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460764, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460765, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013466', 'keratoconjunctivitis sicca', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460766, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003900', 'shortened QT interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460767, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460768, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460769, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002626', 'increased heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460770, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460771, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002333', 'abnormal lung compliance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460772, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002693', 'abnormal pancreas physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460773, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460774, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460775, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010570', 'prolonged ST segment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460776, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460777, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004005', 'impaired contractility of intestinal smooth muscle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460778, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003899', 'abnormal QT interval', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460779, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002322', 'abnormal respiratory transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460780, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000231', 'hypertension', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460781, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460782, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460783, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002472', 'impaired complement alternative pathway', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460784, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460785, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460786, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008009', 'delayed cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460787, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031248', 'increased CCL3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460788, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000740', 'impaired smooth muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460789, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460790, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009668', 'ectopic pregnancy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460791, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460792, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011931', 'abnormal pulmonary valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460793, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460794, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005042', 'abnormal level of surface class II molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460795, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001378', 'abnormal ejaculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460796, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010936', 'decreased airway resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460797, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008566', 'increased interferon-gamma secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460798, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004748', 'increased susceptibility to age-related hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460799, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001861', 'lung inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460800, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013210', 'abnormal primary cilium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460801, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003474', 'abnormal summary potential intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460802, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003477', 'abnormal nerve fiber response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460803, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460804, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014046', 'abnormal mitophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460805, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009698', 'heart hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460806, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004144', 'hypotonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460807, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011925', 'abnormal heart echocardiography feature', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460808, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001313', 'increased incidence of corneal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460809, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011918', 'abnormal PQ interval', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460810, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460811, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002405', 'respiratory system inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460812, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460813, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003475', 'increased summary potential intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460814, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004217', 'salt-sensitive hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460815, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460816, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008748', 'abnormal central T cell anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460817, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460818, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002294', 'short gestation period', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460819, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460820, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011763', 'urethritis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460821, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003762', 'abnormal immune organ physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460822, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011194', 'abnormal hair follicle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460823, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002896', 'abnormal bone mineralization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460824, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010560', 'intraventricular block', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460825, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005575', 'increased pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460826, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460827, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460828, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004738', 'abnormal auditory brainstem response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460829, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460830, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004021', 'abnormal rod electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460831, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010539', 'decreased level of surface class II molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460832, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013498', 'trachea inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460833, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010538', 'increased level of surface class II molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460834, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460835, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460836, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460837, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013135', 'poor circulation in tail', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460838, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010822', 'pneumothorax', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460839, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001837', 'defective assembly of class I molecules', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460840, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009482', 'ileum inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460841, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030130', 'gum inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460842, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031130', 'right-to-left shunt', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460843, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020137', 'decreased bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460844, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013475', 'delayed reproductive senescence', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460845, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003824', 'decreased left ventricle developed pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460846, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031469', 'abnormal pinocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460847, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460848, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011432', 'decreased urine flow rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460849, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003476', 'decreased summary potential intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460850, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008670', 'decreased interleukin-12b secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460851, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030990', 'nerve inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460852, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002128', 'abnormal blood circulation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460853, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460854, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031127', 'dry gangrene', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460855, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008696', 'increased interleukin-3 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460856, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003875', 'abnormal hair follicle regression', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460857, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003480', 'increased nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460858, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460859, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006044', 'tricuspid valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460860, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003698', 'abnormal male reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460861, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011919', 'abnormal R wave', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460862, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460863, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011938', 'prolonged PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460864, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008402', 'increased cellular sensitivity to alkylating agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460865, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003431', 'abnormal parathyroid gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460866, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460867, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003823', 'increased left ventricle developed pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460868, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003292', 'melena', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460869, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010211', 'abnormal acute phase protein level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460870, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020001', 'decreased response to antigen', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460871, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031242', 'increased CSF3 level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460872, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002007', 'increased cellular sensitivity to gamma-irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460873, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010072', 'increased pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460874, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013942', 'enthesitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460875, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030574', 'increased hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460876, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460877, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006388', 'abnormal auditory summating potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460878, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003157', 'impaired muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460879, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009788', 'increased susceptibility to bacterial infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460880, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460881, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000947', 'convulsive seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460882, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003375', 'abnormal menstrual cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460883, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004156', 'abnormal QT variability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460884, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460885, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030822', 'sacroiliac joint inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460886, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005532', 'abnormal vascular resistance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460887, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031222', 'decreased CXCL10 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460888, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001857', 'pericarditis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460889, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031246', 'abnormal CCL3 level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460890, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460891, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002133', 'abnormal respiratory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460892, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008676', 'decreased interleukin-15 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460893, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011444', 'abnormal renal water homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460894, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010073', 'decreased pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460895, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460896, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031009', 'abnormal sperm-egg fusion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460897, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460898, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010634', 'increased QRS amplitude', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460899, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460900, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008995', 'early reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460901, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002988', 'decreased urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460902, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460903, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003741', 'tinnitus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460904, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460905, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030951', 'abnormal endocytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460906, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009349', 'increased urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460907, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008567', 'decreased interferon-gamma secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460908, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011718', 'decreased interleukin-8 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460909, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460910, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000249', 'abnormal blood vessel physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460911, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003089', 'decreased skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460912, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006114', 'cardiac murmur', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460913, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000427', 'abnormal hair cycle', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460914, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005076', 'abnormal cell differentiation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460915, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011418', 'leukocyturia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460916, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460917, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001790', 'abnormal immune system physiology', 0.6363636363636364, 7.400946880077414, 2.1701828192896957, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460918, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000505', 'decreased digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460919, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004022', 'abnormal cone electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460920, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008651', 'increased interleukin-1 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460921, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004513', 'avnosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460922, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013556', 'abnormal holocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460923, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001533', 'abnormal skeleton physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460924, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005410', 'abnormal fertilization', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460925, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460926, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460927, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002164', 'abnormal gland physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460928, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010515', 'abnormal Q wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460929, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005275', 'abnormal skin tensile strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460930, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001194', 'dermatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460931, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460932, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460933, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011832', 'abnormal visual acuity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460934, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460935, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004486', 'decreased response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460936, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009046', 'muscle twitch', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460937, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011805', 'decreased cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460938, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008776', 'increased right ventricle peak pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460939, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460940, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011043', 'abnormal lung elastance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460941, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005000', 'abnormal immune tolerance', 0.6086956521739131, 7.400946880077414, 2.122480668433333, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460942, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460943, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008877', 'abnormal DNA methylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460944, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460945, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003259', 'nausea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460946, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460947, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002293', 'long gestation period', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460948, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000352', 'decreased cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460949, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003866', 'abnormal defecation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460950, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006002', 'abnormal small intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460951, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014041', 'increased cellular sensitivity to cisplatin', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460952, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005621', 'abnormal cell physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460953, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460954, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013208', 'abnormal cilium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460955, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011929', 'abnormal aortic valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460956, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460957, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010368', 'abnormal lymphatic system physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460958, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003011', 'delayed dark adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460959, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010107', 'abnormal renal reabsorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460960, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004743', 'abnormal vestibular evoked myogenic potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460961, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001984', 'abnormal olfaction', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460962, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460963, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003122', 'maternal imprinting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460964, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010155', 'abnormal intestine physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460965, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008652', 'decreased interleukin-1 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460966, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010994', 'aerophagia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460967, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009058', 'decreased interleukin-21 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460968, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002498', 'abnormal acute inflammation', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460969, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006048', 'pulmonary valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460970, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460971, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001756', 'abnormal urination', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460972, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006190', 'retina ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460973, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004994', 'abnormal brain wave pattern', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460974, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031118', 'cardiovalvulitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460975, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005001', 'abnormal clonal deletion', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460976, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460977, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011953', 'prolonged PQ interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460978, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001866', 'nasal inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460979, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460980, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002419', 'abnormal innate immunity', 0.6086956521739131, 7.400946880077414, 2.122480668433333, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460981, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004587', 'decreased cellular sensitivity to X-ray irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460982, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008691', 'decreased interleukin-23 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460983, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009348', 'abnormal urine pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460984, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008700', 'decreased interleukin-4 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460985, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009732', 'ventricular premature beat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460986, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460987, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031423', 'abnormal luteolysis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460988, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003927', 'increased cellular glucose import', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460989, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013632', 'increased femur maximal load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460990, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004829', 'increased anti-chromatin antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460991, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010922', 'alveolitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460992, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031013', 'abnormal egg activation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460993, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003123', 'paternal imprinting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460994, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008565', 'decreased interferon-beta secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460995, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002106', 'abnormal muscle physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460996, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006001', 'abnormal intestinal transit time', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460997, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008685', 'decreased interleukin-18 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(460998, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003901', 'abnormal PR interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(460999, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461000, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003207', 'decreased cellular sensitivity to gamma-irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461001, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020000', 'abnormal response to antigen', 0.6086956521739131, 7.400946880077414, 2.122480668433333, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461002, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003454', 'erythroderma', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461003, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002933', 'joint inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461004, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001542', 'abnormal bone strength', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461005, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000423', 'delayed hair regrowth', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461006, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461007, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008539', 'decreased susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461008, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003260', 'vomiting', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461009, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008712', 'decreased interleukin-9 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461010, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461011, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001867', 'rhinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461012, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001337', 'dry eyes', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461013, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000951', 'sporadic seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461014, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001963', 'abnormal hearing physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461015, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461016, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013641', 'increased vertebra stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461017, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008697', 'decreased interleukin-3 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461018, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461019, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031129', 'left-to-right shunt', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461020, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008678', 'increased interleukin-16 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461021, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001952', 'increased airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461022, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461023, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010513', 'abnormal ventricular activation time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461024, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004925', 'decreased susceptibility to noise-induced hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461025, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461026, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461027, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461028, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005666', 'abnormal adipose tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461029, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005087', 'decreased acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461030, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002409', 'decreased susceptibility to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461031, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461032, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003256', 'biliary cirrhosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461033, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000343', 'abnormal response to cardiac infarction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461034, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004031', 'insulitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461035, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461036, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461037, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008007', 'abnormal cellular replicative senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461038, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003589', 'abnormal ureter physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461039, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031240', 'abnormal CSF3 level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461040, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001839', 'abnormal level of surface class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461041, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001851', 'eye inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461042, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014275', 'increased respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461043, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002578', 'impaired ability to fire action potentials', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461044, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030941', 'enhanced autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461045, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461046, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009358', 'environmentally induced seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461047, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005501', 'abnormal skin physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461048, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003091', 'abnormal cell migration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461049, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461050, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008562', 'increased interferon-alpha secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461051, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004751', 'increased length of allograft survival', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461052, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000743', 'muscle spasm', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461053, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004945', 'abnormal bone resorption', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461054, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461055, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011421', 'cylindruria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461056, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020147', 'abnormal defecation amount', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461057, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031225', 'decreased CXCL10 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461058, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002161', 'abnormal fertility/fecundity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461059, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461060, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010504', 'abnormal RR interval', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461061, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461062, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012125', 'decreased bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461063, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461064, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031128', 'cardiovascular shunt', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461065, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012553', 'decreased serum complement activity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461066, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461067, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009567', 'mitotic nondisjunction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461068, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461069, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005088', 'increased acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461070, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461071, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002314', 'abnormal respiratory mechanics', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461072, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461073, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031090', 'ageusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461074, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461075, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002893', 'ketoaciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461076, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004212', 'abnormal salty taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461077, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461078, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461079, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012685', 'abnormal primitive streak elongation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461080, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008003', 'achlorhydria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461081, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461082, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031053', 'pleuritis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461083, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013561', 'abnormal endocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461084, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003193', 'decreased cholesterol efflux', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461085, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004558', 'delayed allantois development', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461086, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461087, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001914', 'hemorrhage', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461088, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461089, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004010', 'increased diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461090, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008682', 'decreased interleukin-17 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461091, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006042', 'increased apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461092, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011809', 'abnormal anoikis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461093, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010038', 'abnormal placenta physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461094, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461095, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461096, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461097, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001845', 'abnormal inflammatory response', 0.6086956521739131, 7.400946880077414, 2.122480668433333, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461098, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461099, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005333', 'decreased heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461100, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012046', 'decreased susceptibility to hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461101, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009562', 'abnormal odor adaptation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461102, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013638', 'decreased femur stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461103, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010377', 'abnormal gut flora balance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461104, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008750', 'abnormal interferon level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461105, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011758', 'renal ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461106, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010950', 'abnormal lung hysteresivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461107, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461108, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020381', 'muscle gating pore current', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461109, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003096', 'increased corneal light-scattering', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461110, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001598', 'abnormal blood viscosity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461111, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011012', 'bronchiectasis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461112, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003186', 'abnormal redox activity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461113, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005364', 'increased susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461114, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011954', 'shortened PQ interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461115, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461116, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031086', 'wheezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461117, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001947', 'abnormal mucociliary clearance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461118, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461119, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461120, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006082', 'CNS inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461121, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011928', 'abnormal mitral valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461122, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008006', 'increased stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461123, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011824', 'increased cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461124, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461125, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008004', 'abnormal stomach pH', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461126, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461127, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461128, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011013', 'bronchiolectasis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461129, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004879', 'decreased systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461130, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461131, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001935', 'decreased litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461132, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030619', 'homogentisic aciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461133, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005399', 'increased susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461134, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461135, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009661', 'abnormal pregnancy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461136, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008722', 'abnormal chemokine secretion', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461137, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011399', 'increased endoneurial fluid pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461138, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013297', 'abnormal susceptibility to colitis induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461139, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008664', 'decreased interleukin-12 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461140, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461141, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031014', 'polyspermy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461142, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003897', 'abnormal ST segment', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461143, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002987', 'abnormal urine osmolality', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461144, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461145, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461146, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004011', 'decreased diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461147, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030118', 'rhinosinusitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461148, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011045', 'decreased lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461149, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461150, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011220', 'increased intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461151, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004742', 'abnormal vestibular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461152, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003767', 'palate inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461153, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461154, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461155, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001862', 'interstitial pneumonia', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461156, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030132', 'periodontium inflammation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461157, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461158, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008737', 'abnormal spleen physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461159, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003467', 'abnormal single cell response intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461160, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002842', 'increased systemic arterial blood pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461161, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008688', 'decreased interleukin-2 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461162, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002879', 'increased cellular sensitivity to X-ray irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461163, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002796', 'impaired skin barrier function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461164, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000327', 'hemosiderinuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461165, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004760', 'increased mitotic index', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461166, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010520', 'sinoatrial block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461167, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461168, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001841', 'decreased level of surface class I molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461169, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030940', 'impaired autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461170, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013285', 'abnormal renal filtration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461171, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001648', 'abnormal apoptosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461172, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002327', 'abnormal respiratory function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461173, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013640', 'increased bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461174, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461175, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002473', 'impaired complement classical pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461176, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006335', 'abnormal hearing electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461177, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030987', 'spinal cord inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461178, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001869', 'pancreas inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461179, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020974', 'abnormal FO-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461180, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003463', 'abnormal single cell response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461181, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001663', 'abnormal digestive system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461182, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461183, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031089', 'sneezing', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461184, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010393', 'shortened QRS complex duration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461185, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008663', 'increased interleukin-12 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461186, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008679', 'decreased interleukin-16 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461187, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001912', 'increased cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461188, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461189, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004072', 'abnormal frontal plane axis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461190, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005043', 'defective assembly of class II molecules', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461191, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003254', 'bile duct inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461192, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003412', 'abnormal afterhyperpolarization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461193, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461194, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004512', 'anosmia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461195, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004142', 'abnormal muscle tone', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461196, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011431', 'increased urine flow rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461197, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003100', 'myopia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461198, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014028', 'decreased respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461199, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008814', 'decreased nerve conduction velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461200, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014037', 'stranguria', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461201, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461202, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461203, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461204, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461205, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010935', 'increased airway resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461206, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000351', 'increased cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461207, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012610', 'increased complement C5 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461208, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461209, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010334', 'pleural effusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461210, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002935', 'chronic joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461211, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461212, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006265', 'increased pulse pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461213, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010758', 'increased right ventricle systolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461214, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031247', 'decreased CCL3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461215, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004211', 'abnormal sour taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461216, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461217, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011825', 'decreased cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461218, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020220', 'decreased tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461219, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013971', 'blood in lymph vessels', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461220, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461221, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006273', 'abnormal urine organic cation level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461222, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003278', 'esophageal inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461223, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031054', 'bronchiolitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461224, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461225, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003926', 'decreased cellular glucose uptake', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461226, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000751', 'myopathy', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461227, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013806', 'encephalopathy', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461228, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004050', 'abnormal renal sympathetic nerve activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461229, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461230, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000316', 'cellular necrosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461231, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020154', 'impaired humoral immune response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461232, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461233, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004859', 'abnormal synaptic plasticity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461234, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461235, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001752', 'abnormal hypothalamus secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461236, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006047', 'aortic valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461237, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461238, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003997', 'tonic-clonic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461239, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461240, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461241, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001858', 'intestinal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461242, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004009', 'abnormal diastolic filling velocity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461243, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003470', 'abnormal summary potential', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461244, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003280', 'urinary incontinence', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461245, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008272', 'abnormal endochondral bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461246, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461247, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461248, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003928', 'increased heart rate variability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461249, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461250, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461251, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461252, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461253, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003878', 'abnormal ear physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461254, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010946', 'hyperpnea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461255, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020080', 'increased bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461256, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003725', 'increased autoantibody level', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461257, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010751', 'decreased susceptibility to parasitic infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461258, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010992', 'increased surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461259, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003560', 'osteoarthritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461260, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031110', 'meningitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461261, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461262, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006152', 'tunnel vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461263, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009790', 'decreased susceptibility to viral infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461264, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013642', 'decreased vertebra stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461265, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001844', 'autoimmune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461266, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002694', 'abnormal pancreas secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461267, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009275', 'bruising', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461268, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005037', 'mucous diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461269, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020386', 'adipose tissue inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461270, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461271, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004014', 'abnormal uterine environment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461272, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461273, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003039', 'increased time of peak ischemic contracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461274, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011762', 'renal/urinary system inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461275, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461276, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010094', 'abnormal chromosome stability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461277, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461278, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020845', 'abnormal DNA-templated transcription', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461279, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013644', 'increased vertebra maximal load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461280, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461281, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461282, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001924', 'infertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461283, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004244', 'abnormal miscarriage rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461284, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012034', 'abnormal a-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461285, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009645', 'crystalluria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461286, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003393', 'decreased cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461287, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001664', 'abnormal digestion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461288, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013627', 'increased vertebra yield load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461289, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008751', 'abnormal interleukin level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461290, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009247', 'meteorism', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461291, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461292, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008544', 'impaired olfaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461293, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010636', 'bundle branch block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461294, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008687', 'increased interleukin-2 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461295, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009697', 'abnormal copulation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461296, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013636', 'abnormal bone stiffness', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461297, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011046', 'abnormal lung tissue damping', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461298, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003898', 'abnormal QRS complex', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461299, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011467', 'decreased urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461300, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001852', 'conjunctivitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461301, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004216', 'salt-resistant hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461302, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008775', 'abnormal heart ventricle pressure', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461303, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002296', 'aspiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461304, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031102', 'rhinorrhea', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461305, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006266', 'decreased pulse pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461306, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008744', 'abnormal B cell anergy', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461307, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011936', 'abnormal PP interval', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461308, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009791', 'increased susceptibility to viral infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461309, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003699', 'abnormal female reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461310, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012382', 'abnormal blood cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461311, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008673', 'decreased interleukin-13 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461312, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001850', 'increased susceptibility to otitis media', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461313, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002826', 'tonic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461314, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008708', 'increased interleukin-7 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461315, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031224', 'abnormal CXCL10 level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461316, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010895', 'increased lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461317, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030939', 'abnormal autophagosome formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461318, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461319, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031092', 'dysgeusia', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461320, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003341', 'chronic pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461321, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020097', 'low mean heart rate adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461322, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006046', 'atrioventricular valve regurgitation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461323, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461324, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003820', 'increased left ventricle systolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461325, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005515', 'uveitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461326, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461327, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031105', 'rhonchi', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461328, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461329, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001945', 'bronchoconstriction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461330, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013468', 'chromodacryorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461331, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011221', 'decreased intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461332, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003481', 'decreased nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461333, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004878', 'increased systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461334, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000304', 'abnormal cardiac stroke volume', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461335, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0021016', 'decreased tau protein phosphorylation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461336, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031126', 'gangrene', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461337, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461338, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461339, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461340, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461341, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003473', 'decreased summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461342, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008660', 'increased interleukin-10 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461343, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002254', 'reproductive system inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461344, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006150', 'double vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461345, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461346, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002330', 'abnormal bronchial provocation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461347, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011994', 'increased nerve conduction velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461348, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011937', 'shortened PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461349, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461350, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008861', 'abnormal hair shedding', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461351, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461352, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461353, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031066', 'cytokine storm', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461354, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008817', 'hematoma', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461355, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008005', 'decreased stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461356, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461357, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461358, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003192', 'increased cholesterol efflux', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461359, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001986', 'abnormal taste sensitivity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461360, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011951', 'increased cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461361, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013752', 'stridor', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461362, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002090', 'abnormal vision', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461363, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010071', 'abnormal pruritus', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461364, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001948', 'vesicoureteral reflux', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461365, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461366, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012609', 'decreased complement C5 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461367, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014120', 'focal seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461368, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012045', 'increased susceptibility to hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461369, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013145', 'eye discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461370, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003306', 'small intestinal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461371, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010511', 'shortened PR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461372, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461373, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461374, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008693', 'increased interleukin-23a secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461375, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001666', 'abnormal intestinal absorption', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461376, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008684', 'increased interleukin-18 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461377, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461378, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004947', 'skin inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461379, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004122', 'abnormal sinus arrhythmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461380, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005551', 'abnormal eye electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461381, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461382, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009384', 'cardiac valve regurgitation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461383, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005044', 'sepsis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461384, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005403', 'abnormal nerve conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461385, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004046', 'abnormal mitosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461386, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461387, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461388, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461389, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461390, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020848', 'abnormal exocytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461391, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001953', 'respiratory failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461392, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010631', 'increased Q wave amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461393, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008747', 'abnormal T cell anergy', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461394, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004145', 'abnormal muscle electrophysiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461395, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002418', 'increased susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461396, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011952', 'decreased cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461397, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012033', 'abnormal ERG implicit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461398, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461399, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461400, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461401, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009473', 'abnormal skin exfoliation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461402, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003116', 'rickets', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461403, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031051', 'lymph node hemorrhage', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461404, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461405, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003659', 'abnormal lymph circulation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461406, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461407, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030575', 'decreased hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461408, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461409, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012745', 'abnormal neural crest cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461410, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006336', 'abnormal otoacoustic response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461411, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002499', 'chronic inflammation', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461412, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461413, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461414, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009643', 'abnormal urine homeostasis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461415, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461416, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461417, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461418, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031088', 'coughing', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461419, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001859', 'kidney inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461420, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461421, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461422, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012032', 'abnormal ERG latency', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461423, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005251', 'blepharitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461424, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461425, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002934', 'acute joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461426, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008661', 'decreased interleukin-10 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461427, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030924', 'early exit from telogen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461428, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461429, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006003', 'abnormal large intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461430, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461431, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461432, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461433, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011048', 'decreased lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461434, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003868', 'abnormal feces composition', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461435, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461436, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461437, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031223', 'increased CXCL10 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461438, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461439, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010993', 'decreased surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461440, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002338', 'abnormal pulmonary ventilation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461441, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008705', 'increased interleukin-6 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461442, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004143', 'muscle hypertonia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461443, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004781', 'abnormal surfactant composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461444, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001633', 'poor circulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461445, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003009', 'abnormal cytokine secretion', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461446, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010756', 'decreased right ventricle peak pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461447, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003787', 'abnormal imprinting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461448, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461449, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011804', 'increased cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461450, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461451, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001819', 'abnormal immune cell physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461452, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001634', 'internal hemorrhage', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461453, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010750', 'increased susceptibility to parasitic infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461454, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004037', 'increased muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461455, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461456, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011047', 'increased lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461457, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461458, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014132', 'abnormal tear film physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461459, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461460, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011930', 'abnormal tricuspid valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461461, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461462, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008694', 'decreased interleukin-23a secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461463, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461464, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004484', 'abnormal response of heart to induced stress', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461465, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005580', 'periinsulitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461466, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011466', 'increased urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461467, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002909', 'abnormal adrenal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461468, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461469, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000920', 'abnormal myelination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461470, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003465', 'increased single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461471, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001629', 'abnormal heart rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461472, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008713', 'abnormal cytokine level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461473, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461474, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008942', 'abnormal induced cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461475, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001854', 'atrial endocarditis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461476, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008669', 'increased interleukin-12b secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461477, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004796', 'increased anti-histone antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461478, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461479, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003340', 'acute pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461480, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012040', 'abnormal c-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461481, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013559', 'abnormal exocrine gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461482, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003777', 'lip inflammation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461483, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008950', 'ventricular tachycardia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461484, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461485, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031170', 'abnormal vasculature physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461486, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012120', 'trophectoderm cell degeneration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461487, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003482', 'increased nerve fiber response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461488, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031111', 'meningoencephalitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461489, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005671', 'abnormal response to transplant', 0.6086956521739131, 7.400946880077414, 2.122480668433333, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461490, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030909', 'abnormal melanocyte adhesion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461491, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013305', 'isosthenuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461492, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009789', 'decreased susceptibility to bacterial infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461493, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461494, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003483', 'decreased nerve fiber response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461495, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008706', 'decreased interleukin-6 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461496, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006043', 'decreased apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461497, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003925', 'abnormal cellular glucose uptake', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461498, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003304', 'large intestinal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461499, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461500, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003394', 'increased cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461501, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010954', 'abnormal cellular respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461502, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0031098', 'abnormal sputum production', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461503, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013625', 'increased femur yield load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461504, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003882', 'abnormal pulse pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461505, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461506, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006201', 'vitreous body inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461507, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461508, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001849', 'ear inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461509, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030216', 'tongue muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461510, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030214', 'muscle fasciculation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461511, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010514', 'fragmented QRS complex', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461512, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004736', 'abnormal distortion product otoacoustic emission', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461513, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461514, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001985', 'abnormal gustatory system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461515, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008069', 'abnormal joint mobility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461516, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461517, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001761', 'abnormal urination pattern', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461518, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010143', 'enhanced fertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461519, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0020218', 'abnormal tear production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461520, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010741', 'abnormal melanocyte proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461521, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001954', 'respiratory distress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461522, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001847', 'brain inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461523, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461524, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009057', 'increased interleukin-21 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461525, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009350', 'decreased urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461526, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008711', 'increased interleukin-9 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461527, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010752', 'impaired mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461528, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004085', 'abnormal heartbeat', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461529, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001793', 'abnormal susceptibility to infection', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461530, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003077', 'abnormal cell cycle', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461531, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010554', 'shortened HV interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461532, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003034', 'increased pulmonary vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461533, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461534, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006153', 'hypermetropia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461535, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461536, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001927', 'abnormal estrous cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461537, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461538, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012697', 'abnormal maternal body weight gain', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461539, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010695', 'abnormal blood pressure regulation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461540, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0013459', 'perioral dermatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461541, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010505', 'abnormal T wave', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461542, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009045', 'muscle tetany', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461543, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0014048', 'abnormal Peyers patch physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461544, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012608', 'abnormal complement C5 level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461545, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461546, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001921', 'reduced fertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461547, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461548, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461549, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461550, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011923', 'abnormal bladder urine volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461551, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003305', 'proctitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461552, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461553, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461554, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006383', 'abnormal cochlear frequency tuning', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461555, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008002', 'hyperchlorhydria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461556, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461557, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461558, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0010381', 'abnormal dosage compensation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461559, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005036', 'diarrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461560, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0001848', 'choroid inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461561, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008001', 'hypochlorhydria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461562, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0002292', 'abnormal gestational length', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461563, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0003996', 'clonic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461564, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0011900', 'podocyturia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461565, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008699', 'increased interleukin-4 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461566, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461567, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000738', 'impaired muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461568, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0000350', 'abnormal cell proliferation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461569, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0030129', 'tongue inflammation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461570, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0005435', 'hemoperitoneum', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461571, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008271', 'abnormal bone ossification', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461572, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(461573, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0006080', 'brain ischemia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(461574, 'HP:0031383', 'Abnormal lymphocyte surface marker expression', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
